{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":261,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":261,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"6de10d7fb825","filters":{"venue":"Journal for ImmunoTherapy of Cancer"}},"results":[{"id":"W3011642937","doi":"10.1136/jitc-2019-000337","title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","year":2020,"lang":"en","type":"review","venue":"Journal for ImmunoTherapy of Cancer","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1061,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; McMaster University","funders":"National Institute of General Medical Sciences; Associazione Italiana per la Ricerca sul Cancro; Rosetrees Trust; National Institute for Health and Care Research; Compagnia di San Paolo; National Cancer Institute; Cancer Research UK; Weill Cornell Medical College; U.S. Department of Defense","keywords":"Acquired immune system; Immune system; Programmed cell death; Immunogenic cell death; Antigenicity; Immunology; Medicine; Computer science; Biology; Antigen; Immunotherapy; Apoptosis","authors":[{"name":"Lorenzo Galluzzi","is_ca":false},{"name":"Ilio Vitale","is_ca":false},{"name":"Sarah H. Warren","is_ca":false},{"name":"Sandy Adjemian","is_ca":false},{"name":"Patrizia Agostinis","is_ca":false},{"name":"Aitziber Buqué Martinez","is_ca":false},{"name":"Timothy A. Chan","is_ca":false},{"name":"George Coukos","is_ca":false},{"name":"Sandra Demaria","is_ca":false},{"name":"Éric Deutsch","is_ca":false},{"name":"Dobrin Draganov","is_ca":false},{"name":"Richard L. Edelson","is_ca":false},{"name":"Silvia C. Formenti","is_ca":false},{"name":"Jitka Fučíková","is_ca":false},{"name":"Lucia Gabriele","is_ca":false},{"name":"Udo S. Gaipl","is_ca":false},{"name":"Sofia R. Gameiro","is_ca":false},{"name":"Abhishek D. Garg","is_ca":false},{"name":"Encouse B. Golden","is_ca":false},{"name":"Jian Han","is_ca":false},{"name":"Kevin J. Harrington","is_ca":false},{"name":"Akseli Hemminki","is_ca":false},{"name":"James W. Hodge","is_ca":false},{"name":"Dewan Md Sakib Hossain","is_ca":false},{"name":"Tim Illidge","is_ca":false},{"name":"Michael Karin","is_ca":false},{"name":"Howard L. Kaufman","is_ca":false},{"name":"Oliver Kepp","is_ca":false},{"name":"Guido Kroemer","is_ca":false},{"name":"Juan José Lasarte","is_ca":false},{"name":"Sherene Loi","is_ca":false},{"name":"Michael T. Lotze","is_ca":false},{"name":"Gwenola Manic","is_ca":false},{"name":"Taha Merghoub","is_ca":false},{"name":"Alan Melcher","is_ca":false},{"name":"Karen Mossman","is_ca":true},{"name":"Felipe Prósper","is_ca":false},{"name":"Øystein Rekdal","is_ca":false},{"name":"María Rescigno","is_ca":false},{"name":"Chiara Riganti","is_ca":false},{"name":"Antonella Sistigu","is_ca":false},{"name":"Mark J. Smyth","is_ca":false},{"name":"Radek Špíšek","is_ca":false},{"name":"John Stagg","is_ca":true},{"name":"Bryan E. Strauss","is_ca":false},{"name":"Daolin Tang","is_ca":false},{"name":"Kazuki Tatsuno","is_ca":false},{"name":"Stefaan Van Gool","is_ca":false},{"name":"Peter Vandenabeele","is_ca":false},{"name":"Takahiro Yamazaki","is_ca":false},{"name":"Dmitriy Zamarin","is_ca":false},{"name":"Laurence Zitvogel","is_ca":false},{"name":"Alessandra Cesano","is_ca":false},{"name":"Francesco M. Marincola","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1025040397579904,"gpt":0.3887354754580861,"spread":0.2862314357000957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01006313,0.001821373,0.002565259,0.006052491,0.0007649511,0.002705359,0.004641632,0.004501206,0.006725334],"category_scores_gemma":[0.01143872,0.0007166226,0.002258793,0.003677565,0.002134344,0.00310148,0.002160718,0.005543126,0.006091343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002526477,"about_ca_system_score_gemma":0.007920339,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002456311,"about_ca_topic_score_gemma":0.002794253,"domain_scores_codex":[0.9958695,0.001016245,0.001122992,0.0003751587,0.001401783,0.0002143065],"domain_scores_gemma":[0.9915645,0.003507668,0.0008875057,0.0003923884,0.003265712,0.000382178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001235187,0.0001036262,0.0002878372,0.02947993,0.0001740779,0.000433504,0.0002501327,0.0005137222,0.002132231,0.02603185,0.2145612,0.7259083],"study_design_scores_gemma":[0.00002038613,0.00004895559,0.0002953476,0.009770341,0.0001325976,0.000880503,0.0000736178,0.00007872724,0.0005279119,0.005808486,0.9823308,0.00003220838],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001685639,0.9711092,0.005809102,0.00925325,0.006271072,0.0002056885,0.0004074806,0.0001350096,0.006640713],"genre_scores_gemma":[0.00181451,0.9660817,0.01623615,0.006705455,0.002589728,0.0005087176,0.001108462,0.0000549359,0.004900389],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01006313,"threshold_uncertainty_score":0.05321956,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2952406594","doi":"10.1186/s40425-017-0215-8","title":"Gene expression markers of Tumor Infiltrating Leukocytes","year":2017,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":850,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute","keywords":"Immune system; Biology; Gene; Gene expression; Immunotherapy; Flow cytometry; Gene expression profiling; Computational biology; Genetics","authors":[{"name":"Patrick Danaher","is_ca":false},{"name":"Sarah Warren","is_ca":false},{"name":"Lucas Dennis","is_ca":false},{"name":"Leonard D’Amico","is_ca":false},{"name":"Andrew White","is_ca":false},{"name":"Mary L. Disis","is_ca":false},{"name":"Melissa A. Geller","is_ca":true},{"name":"Kunle Odunsi","is_ca":false},{"name":"Joseph Beechem","is_ca":false},{"name":"Steven P. Fling","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02844187749003703,"gpt":0.3487739243891307,"spread":0.3203320468990937,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002491007,0.0002208427,0.0002160545,0.001050138,0.0001193405,0.0004252799,0.000154293,0.0002213189,0.001092231],"category_scores_gemma":[0.0006686937,0.00006253993,0.0001712042,0.001441295,0.0001477119,0.000159924,0.000179141,0.0001985731,0.000363377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002006591,"about_ca_system_score_gemma":0.0001475111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002194979,"about_ca_topic_score_gemma":0.0003329466,"domain_scores_codex":[0.9997332,0.00003744497,0.0000218385,0.0001035902,0.00006307547,0.00004099778],"domain_scores_gemma":[0.9995207,0.0001490143,0.0001872036,0.00003370887,0.00006678738,0.00004253552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0009637391,0.0001133013,0.3711561,0.0003836287,0.0001440053,0.0002277725,0.0001603168,0.00148883,0.5672081,0.0004395972,0.0007549881,0.05695971],"study_design_scores_gemma":[0.00004823614,0.0006616111,0.7453007,0.00004762096,0.000287658,0.001253133,0.0002842873,0.006368665,0.236231,0.0010938,0.008399409,0.00002382237],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851362,0.002241309,0.006993376,0.00006798115,0.0000165389,0.00003722346,0.004231487,0.0001148479,0.001161029],"genre_scores_gemma":[0.9877484,0.0007033324,0.006948308,0.00005829076,0.0000213541,0.000102797,0.003752908,0.00002333801,0.0006413253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001092231,"threshold_uncertainty_score":0.003653884,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2958648554","doi":"10.1186/s40425-019-0662-5","title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":738,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"National Center for Advancing Translational Sciences; University of Texas MD Anderson Cancer Center; National Institute for Health and Care Research; Cancer Research UK; Yale University; Society for Immunotherapy of Cancer; Università degli Studi di Milano; Brigham and Women's Hospital; Yale Cancer Center; Memorial Sloan-Kettering Cancer Center","keywords":"Pembrolizumab; Medicine; Nivolumab; Head and neck squamous-cell carcinoma; Oncology; Internal medicine; Immunotherapy; Cancer; Head and neck cancer; Population","authors":[{"name":"Ezra E.W. Cohen","is_ca":false},{"name":"R. Bryan Bell","is_ca":false},{"name":"Carlo Bifulco","is_ca":false},{"name":"Barbara Burtness","is_ca":false},{"name":"Maura L. Gillison","is_ca":false},{"name":"Kevin J. Harrington","is_ca":true},{"name":"Quynh‐Thu Le","is_ca":false},{"name":"Nancy Y. Lee","is_ca":false},{"name":"Rom S. Leidner","is_ca":false},{"name":"Rebecca Lewis","is_ca":false},{"name":"Lisa Licitra","is_ca":false},{"name":"Hisham Mehanna","is_ca":false},{"name":"Loren K. Mell","is_ca":false},{"name":"Adam Raben","is_ca":false},{"name":"Andrew G. Sikora","is_ca":false},{"name":"Ravindra Uppaluri","is_ca":false},{"name":"Fernanda Whitworth","is_ca":false},{"name":"Dan P. Zandberg","is_ca":false},{"name":"Robert L. Ferris","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02314064955390921,"gpt":0.3334324786407749,"spread":0.3102918290868656,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01135711,0.001807164,0.002517219,0.002422689,0.001782246,0.005030993,0.004121441,0.009889809,0.01092841],"category_scores_gemma":[0.01289982,0.0008665551,0.002514828,0.003331433,0.001523753,0.002489641,0.004934921,0.01390953,0.01450715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004541694,"about_ca_system_score_gemma":0.0236294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005512808,"about_ca_topic_score_gemma":0.009769385,"domain_scores_codex":[0.989902,0.003092772,0.000909292,0.0006622847,0.004283715,0.00114982],"domain_scores_gemma":[0.9817842,0.00152181,0.002472159,0.0006777036,0.01052734,0.003016762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009909927,0.0001063569,0.0003724275,0.001190059,0.00007245432,0.00008471811,0.00006212976,0.0002561285,0.000836784,0.002607798,0.8801046,0.1142074],"study_design_scores_gemma":[0.0001117854,0.0001217493,0.0006203785,0.00102867,0.00004833971,0.0002310976,0.00004111998,0.000116195,0.0002817533,0.001234195,0.9961457,0.00001908695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003419832,0.3094409,0.01030069,0.3505876,0.1683646,0.002906078,0.007953015,0.001528193,0.145499],"genre_scores_gemma":[0.02199531,0.4441702,0.03303759,0.227615,0.05898445,0.00875379,0.03698345,0.000975058,0.1674851],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01135711,"threshold_uncertainty_score":0.06006289,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2905817704","doi":"10.1186/s40425-018-0479-7","title":"High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors","year":2018,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":571,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Immunotherapy; Medicine; Melanoma; Phenotype; Immune checkpoint; Immunology; Cancer research; Cancer; Biology; Internal medicine; Gene","authors":[{"name":"Saman Maleki Vareki","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01551774962185,"gpt":0.3085602037906005,"spread":0.2930424541687505,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004240493,0.00009942919,0.0002693332,0.0004008813,0.0001345975,0.0004491202,0.0001147578,0.0003010911,0.002478888],"category_scores_gemma":[0.001473494,0.0000659459,0.0002306155,0.0002577237,0.0001909928,0.0003659014,0.000183481,0.0004243883,0.0002113525],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001892554,"about_ca_system_score_gemma":0.0001082216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002981972,"about_ca_topic_score_gemma":0.0005670011,"domain_scores_codex":[0.9997111,0.0000813513,0.00002578901,0.00004773483,0.0000539481,0.00008011283],"domain_scores_gemma":[0.9988291,0.0003680022,0.0004539984,0.00004221554,0.00005756429,0.0002491393],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008600721,0.0002702772,0.9520963,0.00007633741,0.0001794053,0.0002869299,0.0001020681,0.0003431072,0.009671254,0.0002221316,0.0007601972,0.02739131],"study_design_scores_gemma":[0.00002591675,0.0006232691,0.9967344,0.00001123089,0.00005277097,0.0005406546,0.0001227305,0.0002736599,0.000836559,0.0001656199,0.0006085113,0.000004684843],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966462,0.001439722,0.000109995,0.0001639222,0.0000166441,0.000008418159,0.0001944391,0.000006125661,0.00141452],"genre_scores_gemma":[0.9990911,0.0001609745,0.00005302874,0.00005653764,0.00002149175,0.000006898435,0.0001561111,0.000002285278,0.0004515794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002478888,"threshold_uncertainty_score":0.008292735,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2948662515","doi":"10.1186/s40425-019-0623-z","title":"Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":438,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada); Royal Ottawa Mental Health Centre","funders":"National Institute for Health and Care Research; Amgen","keywords":"Medicine; Oncolytic virus; Internal medicine; Melanoma; Confidence interval; Oncology; Hazard ratio; Randomized controlled trial; Cancer; Cancer research","authors":[{"name":"Robert H.I. Andtbacka","is_ca":false},{"name":"Frances A. Collichio","is_ca":false},{"name":"Kevin J. Harrington","is_ca":true},{"name":"Mark R. Middleton","is_ca":false},{"name":"Gerald Downey","is_ca":true},{"name":"Katarina Öhrling","is_ca":false},{"name":"Howard L. Kaufman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05177845107064362,"gpt":0.3877663574224503,"spread":0.3359879063518067,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009030502,0.001494698,0.001963903,0.0004883294,0.0003374072,0.001117383,0.0008740836,0.001044548,0.005512248],"category_scores_gemma":[0.005694953,0.0006002408,0.003767223,0.0002571778,0.000697914,0.0006876342,0.0005395527,0.002523195,0.0008337867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008698223,"about_ca_system_score_gemma":0.00135908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003555927,"about_ca_topic_score_gemma":0.0009436969,"domain_scores_codex":[0.9972143,0.001983624,0.0001039438,0.0002671354,0.0002206819,0.0002104724],"domain_scores_gemma":[0.9971034,0.001071426,0.0007735911,0.00028366,0.0002538465,0.000514064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.971638,0.002518622,0.002259087,0.0003864958,0.002501538,0.00005098624,0.0000591453,0.001724513,0.00357145,0.0002526488,0.003442464,0.01159513],"study_design_scores_gemma":[0.8187901,0.1511322,0.01349436,0.00007465982,0.00496362,0.000136266,0.00004313403,0.002940916,0.003203116,0.0008562024,0.004320335,0.00004506006],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9617707,0.004861686,0.004455878,0.001572278,0.0004617749,0.01063141,0.009451811,0.0003551223,0.006439281],"genre_scores_gemma":[0.9680821,0.001253359,0.006098715,0.001467553,0.0003394399,0.007901907,0.008872935,0.0001076923,0.005876325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009030502,"threshold_uncertainty_score":0.04775846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4206897023","doi":"10.1136/jitc-2021-003777","title":"Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":322,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC; University of Calgary; Université de Montréal; McGill University Health Centre","funders":"National Cancer Institute; GlaxoSmithKline","keywords":"Medicine; Cohort; Endometrial cancer; Internal medicine; Microsatellite instability; Interim analysis; Interim; Oncology; Adverse effect; Cancer; Clinical trial; Biology; Microsatellite","authors":[{"name":"Ana Oaknin","is_ca":false},{"name":"Lucy Gilbert","is_ca":true},{"name":"Anna V. Tinker","is_ca":true},{"name":"Jubilee Brown","is_ca":false},{"name":"Cara Mathews","is_ca":false},{"name":"Joshua Z. Press","is_ca":false},{"name":"Renaud Sabatier","is_ca":false},{"name":"David M. O’Malley","is_ca":false},{"name":"Vanessa Samouëlian","is_ca":true},{"name":"Valentina Boni","is_ca":false},{"name":"Linda Duska","is_ca":false},{"name":"Sharad Ghamande","is_ca":false},{"name":"Prafull Ghatage","is_ca":true},{"name":"Rebecca Kristeleit","is_ca":false},{"name":"Charles A. Leath","is_ca":false},{"name":"Wei Guo","is_ca":false},{"name":"Ellie Im","is_ca":false},{"name":"S. Zildjian","is_ca":false},{"name":"Xinwei Han","is_ca":false},{"name":"Tao Duan","is_ca":false},{"name":"Jennifer Veneris","is_ca":false},{"name":"Bhavana Pothuri","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03358148845380517,"gpt":0.3416970790202096,"spread":0.3081155905664045,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001391759,0.0006378535,0.001394741,0.0002830437,0.0002062336,0.0005935452,0.0003806493,0.0006010153,0.001061537],"category_scores_gemma":[0.0008885111,0.0002575493,0.0007887355,0.0002560699,0.0004576657,0.0005520717,0.0002106654,0.001149425,0.0003508336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005613875,"about_ca_system_score_gemma":0.000541156,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001965957,"about_ca_topic_score_gemma":0.0004509653,"domain_scores_codex":[0.9995851,0.000198476,0.00003588776,0.00006860428,0.00005861972,0.00005331394],"domain_scores_gemma":[0.9994265,0.0001354542,0.0001709351,0.00005895654,0.00003277701,0.0001754006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5642649,0.0203171,0.05947364,0.0009776795,0.001605285,0.0004790271,0.000488409,0.005147405,0.09169626,0.0002298392,0.002613273,0.2527071],"study_design_scores_gemma":[0.1693522,0.651706,0.1483562,0.00009262598,0.001349486,0.001494809,0.0001563304,0.004855174,0.01731817,0.0003706573,0.004884257,0.00006410456],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973173,0.001671986,0.0001300779,0.00009983124,0.00001485864,0.0001285622,0.0002026997,0.00002305103,0.0004117423],"genre_scores_gemma":[0.9979759,0.0005420228,0.0002654936,0.0001506022,0.00002894553,0.0001345857,0.0006030528,0.000006778446,0.0002926977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001394741,"threshold_uncertainty_score":0.007360399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210910593","doi":"10.1136/jitc-2021-003534","title":"Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Novelis (Canada)","funders":"High-level Hospital Construction Project of Guangdong Provincial People's Hospital; National Natural Science Foundation of China","keywords":"Immunotherapy; Cancer research; Epidermal growth factor receptor; Tumor microenvironment; CD8; Adenocarcinoma; Immune system; Lung cancer; Biology; Cell; Cytotoxic T cell; Immune checkpoint; Medicine; Cancer; Immunology; Pathology; Internal medicine","authors":[{"name":"Lei Yang","is_ca":false},{"name":"Yun-Ting He","is_ca":false},{"name":"Song Dong","is_ca":false},{"name":"Xue‐Wu Wei","is_ca":false},{"name":"Zhihong Chen","is_ca":false},{"name":"Bo Zhang","is_ca":true},{"name":"Weidong Chen","is_ca":true},{"name":"Xiaorong Yang","is_ca":false},{"name":"Fen Wang","is_ca":false},{"name":"Xue-Meng Shang","is_ca":false},{"name":"Wen‐Zhao Zhong","is_ca":false},{"name":"Yi‐Long Wu","is_ca":false},{"name":"Qing Zhou","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01319586278171577,"gpt":0.2763019632293139,"spread":0.2631061004475982,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001104772,0.0001198913,0.0003328473,0.0001924718,0.0001798504,0.000301003,0.00009295835,0.0002122746,0.0004809207],"category_scores_gemma":[0.0001677852,0.00009688795,0.0002653183,0.0002336154,0.0001339667,0.0001400122,0.0001669129,0.0002452182,0.0001798482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001361788,"about_ca_system_score_gemma":0.0001291907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000699946,"about_ca_topic_score_gemma":0.001097735,"domain_scores_codex":[0.9998968,0.000007924938,0.000006507317,0.00004256463,0.00002837009,0.00001778819],"domain_scores_gemma":[0.9999279,0.00001673264,0.00001477751,0.000008063611,0.00002018726,0.00001242324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0001068086,0.00001308855,0.009179669,0.00005290225,0.00001388737,0.00007597472,0.00007636021,0.000245139,0.9867951,0.00003481904,0.00008806273,0.003318159],"study_design_scores_gemma":[0.00001454134,0.0004196891,0.6617119,0.00002141857,0.0001170891,0.0009528191,0.0007368685,0.01506473,0.3157247,0.0003041799,0.004898632,0.0000333555],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945307,0.0005606355,0.003065288,0.00003454863,0.00001213604,0.00001060374,0.001325585,0.00005381575,0.0004067046],"genre_scores_gemma":[0.9935946,0.0003266747,0.002897759,0.00006829943,0.000007496507,0.00003931277,0.002373956,0.00002526838,0.0006667501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000699946,"threshold_uncertainty_score":0.001608849,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2612327959","doi":"10.1186/s40425-017-0243-4","title":"Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy","year":2017,"lang":"en","type":"review","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Immunotherapy; Immune system; Medicine; Tumor microenvironment; Cancer immunotherapy; Cancer; Immunology; Baseline (sea); Biomarker; Bioinformatics; Oncology; Internal medicine; Biology","authors":[{"name":"Sacha Gnjatic","is_ca":false},{"name":"Vincenzo Bronte","is_ca":false},{"name":"Laura Rosa Brunet","is_ca":false},{"name":"Marcus O. Butler","is_ca":true},{"name":"Mary L. Disis","is_ca":false},{"name":"Jérôme Galon","is_ca":false},{"name":"Leif Håkansson","is_ca":false},{"name":"Brent A. Hanks","is_ca":false},{"name":"Vaios Karanikas","is_ca":false},{"name":"Samir N. Khleif","is_ca":false},{"name":"John M. Kirkwood","is_ca":false},{"name":"Lance D. Miller","is_ca":false},{"name":"Dolores J. Schendel","is_ca":false},{"name":"Isabelle Tanneau","is_ca":false},{"name":"Jon M. Wigginton","is_ca":false},{"name":"Lisa H. Butterfield","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1856874467329706,"gpt":0.511312647124004,"spread":0.3256252003910334,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002249007,0.001071059,0.002630495,0.002360835,0.0001892499,0.001375084,0.00120381,0.001455452,0.001472168],"category_scores_gemma":[0.003664445,0.0002617956,0.001060019,0.001576052,0.0005477995,0.00135666,0.0006560542,0.002664122,0.001085514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009295869,"about_ca_system_score_gemma":0.001453068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009179495,"about_ca_topic_score_gemma":0.00119343,"domain_scores_codex":[0.9993713,0.0001768287,0.0001083261,0.0001048819,0.0001858232,0.00005283077],"domain_scores_gemma":[0.9982598,0.0009426897,0.0002101763,0.00004189794,0.0004844348,0.00006099754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001982438,0.00009252194,0.002371559,0.01074097,0.0003237483,0.0001312536,0.0000431657,0.0005539785,0.001044467,0.003353405,0.02203866,0.9591081],"study_design_scores_gemma":[0.00009811177,0.0004491874,0.013496,0.02417198,0.001432903,0.002827227,0.0001846945,0.0009485946,0.002742893,0.009749535,0.9437911,0.0001077498],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001958372,0.9981815,0.0002701744,0.0006191324,0.0002309741,0.000008707899,0.00003158968,0.000007332534,0.0004547493],"genre_scores_gemma":[0.003066952,0.9950369,0.0006251947,0.0004350276,0.0003317627,0.00002802327,0.00009660095,0.000002750391,0.000376767],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002630495,"threshold_uncertainty_score":0.01189399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3202872245","doi":"10.1136/jitc-2021-003467","title":"Acute kidney injury in patients treated with immune checkpoint inhibitors","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Thomas Hospital; University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Acute kidney injury; Renal function; Internal medicine; Creatinine; Odds ratio; Proportional hazards model; Biopsy; Urology; Gastroenterology","authors":[{"name":"Shruti Gupta","is_ca":false},{"name":"Samuel Short","is_ca":false},{"name":"Meghan E. Sise","is_ca":false},{"name":"Jason Prosek","is_ca":false},{"name":"Sethu M. Madhavan","is_ca":false},{"name":"María José Soler","is_ca":false},{"name":"Marlies Ostermann","is_ca":false},{"name":"Sandra M. Herrmann","is_ca":false},{"name":"Ala Abudayyeh","is_ca":false},{"name":"Shuchi Anand","is_ca":false},{"name":"Ilya Glezerman","is_ca":false},{"name":"Shveta S. Motwani","is_ca":false},{"name":"Naoka Murakami","is_ca":false},{"name":"Rimda Wanchoo","is_ca":false},{"name":"David I. Ortiz-Melo","is_ca":false},{"name":"Arash Rashidi","is_ca":false},{"name":"Ben Sprangers","is_ca":false},{"name":"Vikram Aggarwal","is_ca":false},{"name":"Abhinav Malik","is_ca":false},{"name":"Sebastian Loew","is_ca":false},{"name":"Christopher A. Carlos","is_ca":false},{"name":"Wei‐Ting Chang","is_ca":false},{"name":"Pazit Beckerman","is_ca":false},{"name":"Zain Mithani","is_ca":false},{"name":"Chintan V. Shah","is_ca":false},{"name":"Amanda DeMauro Renaghan","is_ca":false},{"name":"Sophie de Seigneux","is_ca":false},{"name":"Luca Campedel","is_ca":false},{"name":"Abhijat Kitchlu","is_ca":true},{"name":"Daniel Sanghoon Shin","is_ca":false},{"name":"Sunil Rangarajan","is_ca":false},{"name":"Priya Deshpande","is_ca":false},{"name":"Gaia Coppock","is_ca":false},{"name":"Mark Eijgelsheim","is_ca":false},{"name":"Harish Seethapathy","is_ca":false},{"name":"Meghan Lee","is_ca":false},{"name":"Ian A. Strohbehn","is_ca":false},{"name":"Dwight H. Owen","is_ca":false},{"name":"Marium Husain","is_ca":false},{"name":"Clara García-Carro","is_ca":false},{"name":"Sheila Bermejo","is_ca":false},{"name":"Nuttha Lumlertgul","is_ca":true},{"name":"Nina Seylanova","is_ca":true},{"name":"Lucy Flanders","is_ca":true},{"name":"Busra Isik","is_ca":false},{"name":"Omar Mamlouk","is_ca":false},{"name":"Jamie S. Lin","is_ca":false},{"name":"Pablo García","is_ca":false},{"name":"Aydin Kaghazchi","is_ca":false},{"name":"Yuriy Khanin","is_ca":false},{"name":"Sheru Kansal","is_ca":false},{"name":"Els Wauters","is_ca":false},{"name":"Sunandana Chandra","is_ca":false},{"name":"Kai M. Schmidt‐Ott","is_ca":false},{"name":"Raymond K. Hsu","is_ca":false},{"name":"Maria Clarissa Tio","is_ca":false},{"name":"Suraj Sarvode Mothi","is_ca":false},{"name":"Harkarandeep Singh","is_ca":false},{"name":"Deborah Schrag","is_ca":false},{"name":"Kenar D. Jhaveri","is_ca":false},{"name":"Kerry L. Reynolds","is_ca":false},{"name":"Frank B. Cortazar","is_ca":false},{"name":"David E. Leaf","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008752036805244228,"gpt":0.2927027088432207,"spread":0.2839506720379765,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006260916,0.0001389115,0.0004687296,0.0003542581,0.0003666624,0.000568227,0.0002280448,0.0002435041,0.001113502],"category_scores_gemma":[0.002357154,0.00014265,0.0005298985,0.0009220634,0.0001804647,0.000317133,0.0004337243,0.0006754163,0.0001094419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003625721,"about_ca_system_score_gemma":0.0005017909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001555309,"about_ca_topic_score_gemma":0.001682673,"domain_scores_codex":[0.9993908,0.0001436202,0.000093371,0.0001195938,0.0001370627,0.000115508],"domain_scores_gemma":[0.9977345,0.0003182782,0.001515848,0.00007109423,0.0001185626,0.0002416417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001158589,0.00001916247,0.9983817,0.00002006116,0.00004399794,0.00009789852,0.00001539639,0.00003804971,0.00005902722,0.00001390906,0.0000847052,0.001110222],"study_design_scores_gemma":[0.0000246598,0.0001891644,0.9979385,0.00002660444,0.00004543558,0.0009661093,0.00007924566,0.0002344872,0.00006316533,0.00004506828,0.0003843108,0.000003321766],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972879,0.001476922,0.0001332942,0.0001313656,0.00001376812,0.0000178193,0.0003932079,0.000004684741,0.0005410619],"genre_scores_gemma":[0.9991081,0.000322077,0.00008147035,0.00006954069,0.0000241386,0.000009244588,0.0003282131,9.363167e-7,0.00005607471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001555309,"threshold_uncertainty_score":0.003725052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3042095160","doi":"10.1136/jitc-2020-000891","title":"Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"Bristol-Myers Squibb; Ono Pharmaceutical; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; University of Texas MD Anderson Cancer Center","keywords":"Nivolumab; Medicine; Sunitinib; Ipilimumab; Renal cell carcinoma; Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Immunotherapy; Cancer","authors":[{"name":"Robert J. Motzer","is_ca":false},{"name":"Bernard Escudier","is_ca":false},{"name":"David F. McDermott","is_ca":false},{"name":"Osvaldo Arén Frontera","is_ca":false},{"name":"Bohuslav Melichar","is_ca":false},{"name":"Thomas Powles","is_ca":false},{"name":"Frede Donskov","is_ca":false},{"name":"Elizabeth R. Plimack","is_ca":false},{"name":"Philippe Barthélémy","is_ca":false},{"name":"Hans J. Hammers","is_ca":false},{"name":"Saby George","is_ca":false},{"name":"Viktor Grünwald","is_ca":false},{"name":"Camillo Porta","is_ca":false},{"name":"Victoria Neiman","is_ca":false},{"name":"Alain Ravaud","is_ca":false},{"name":"Toni K. Choueiri","is_ca":false},{"name":"Brian I. Rini","is_ca":false},{"name":"Pamela Salman","is_ca":false},{"name":"Christian Kollmannsberger","is_ca":true},{"name":"Scott S. Tykodi","is_ca":false},{"name":"Marc‐Oliver Grimm","is_ca":false},{"name":"Howard Gurney","is_ca":false},{"name":"Raya Leibowitz‐Amit","is_ca":false},{"name":"Poul Geertsen","is_ca":false},{"name":"Asim Amin","is_ca":false},{"name":"Yoshihiko Tomita","is_ca":false},{"name":"M. Brent McHenry","is_ca":false},{"name":"Shruti Shally Saggi","is_ca":false},{"name":"Nizar M. Tannir","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04926157250532811,"gpt":0.3799343260798284,"spread":0.3306727535745003,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007920773,0.001549559,0.002862857,0.0004472898,0.0008058517,0.001514412,0.001059998,0.001943732,0.003575804],"category_scores_gemma":[0.004507714,0.0005788888,0.004515724,0.0005394498,0.001208057,0.00167831,0.0006867353,0.003869429,0.0007101443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001571453,"about_ca_system_score_gemma":0.001937369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007487682,"about_ca_topic_score_gemma":0.001747178,"domain_scores_codex":[0.9970711,0.001883101,0.0001982237,0.000387404,0.0001956097,0.0002643907],"domain_scores_gemma":[0.9953907,0.0009848466,0.001710528,0.0004547073,0.0003017235,0.001157546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9717891,0.007541189,0.004788685,0.0002691463,0.002046179,0.00003202231,0.00006773455,0.0004852355,0.001091598,0.00004515102,0.0006943506,0.01114958],"study_design_scores_gemma":[0.8052247,0.170584,0.01856909,0.00005324503,0.002112951,0.00008494368,0.00004742943,0.001329765,0.0008039385,0.0003122567,0.0008401073,0.00003769583],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915285,0.003120333,0.0003493703,0.0005246765,0.0002056549,0.002297345,0.0009241567,0.00006133151,0.000988566],"genre_scores_gemma":[0.9933364,0.0008134764,0.0006085351,0.0005760083,0.0002694159,0.002660897,0.001080639,0.00001237314,0.0006423135],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007920773,"threshold_uncertainty_score":0.04188955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3190341154","doi":"10.1186/s40425-015-0078-9","title":"Pembrolizumab","year":2015,"lang":"id","type":"review","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Pembrolizumab; Ipilimumab; Medicine; Melanoma; Oncology; Internal medicine; Lung cancer; Nivolumab; Cancer; Immunotherapy; Cancer research","authors":[{"name":"Leila Khoja","is_ca":true},{"name":"Marcus O. Butler","is_ca":true},{"name":"Soonmo Peter Kang","is_ca":false},{"name":"Scot Ebbinghaus","is_ca":false},{"name":"Anthony M. Joshua","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06837773108908334,"gpt":0.4185399310356333,"spread":0.35016219994655,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001749931,0.0005700269,0.000635826,0.001222463,0.0002539706,0.0006434712,0.0004221993,0.0006312711,0.007552125],"category_scores_gemma":[0.0003243861,0.0001584462,0.0004028284,0.0006337436,0.0001670332,0.0006897324,0.0003779824,0.001622265,0.004673371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004642945,"about_ca_system_score_gemma":0.0004040762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008350923,"about_ca_topic_score_gemma":0.00182278,"domain_scores_codex":[0.9998877,0.00001529192,0.00001462154,0.00002548304,0.00004274075,0.00001409954],"domain_scores_gemma":[0.9999474,0.00001610286,0.00001178025,0.000002400005,0.00001459094,0.000007707353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009955497,0.00006837538,0.0001287992,0.004606094,0.00007903474,0.0002927926,0.00002367585,0.0001352629,0.00228987,0.001586142,0.03750495,0.9531856],"study_design_scores_gemma":[0.00006184627,0.00006960249,0.0005256747,0.001142144,0.00007615437,0.002760293,0.00001175116,0.00006284171,0.001002542,0.0007712179,0.9935076,0.000008429644],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005167373,0.9889976,0.0003869641,0.0006173102,0.0004546068,0.00002633756,0.0000880685,0.00003441066,0.008877872],"genre_scores_gemma":[0.006534046,0.9813941,0.000767,0.001381268,0.0004639786,0.00003962078,0.0002872796,0.000005208643,0.009127537],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007552125,"threshold_uncertainty_score":0.02526432,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2060260809","doi":"10.1186/s40425-015-0055-3","title":"Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results","year":2015,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Immunotherapy; Internal medicine; Clinical endpoint; Oncology; Progression-free survival; Phases of clinical research; Surgery; Urology; Gastroenterology; Overall survival; Clinical trial; Cancer","authors":[{"name":"Asim Amin","is_ca":false},{"name":"Arkadiusz Z. Dudek","is_ca":false},{"name":"Theodore F. Logan","is_ca":false},{"name":"Raymond S. Lance","is_ca":false},{"name":"Jeffrey M. Holzbeierlein","is_ca":false},{"name":"Jennifer J. Knox","is_ca":true},{"name":"Viraj A. Master","is_ca":false},{"name":"Sumanta K. Pal","is_ca":false},{"name":"Wilson H. Miller","is_ca":true},{"name":"Lawrence I. Karsh","is_ca":false},{"name":"Irina Y. Tcherepanova","is_ca":false},{"name":"Mark DeBenedette","is_ca":false},{"name":"W. L. Williams","is_ca":false},{"name":"Douglas C Plessinger","is_ca":false},{"name":"Charles A. Nicolette","is_ca":false},{"name":"Robert A. Figlin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02350134221702204,"gpt":0.3124838008042494,"spread":0.2889824585872273,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008618499,0.0007077394,0.0009243816,0.0001978206,0.0002141753,0.0004603866,0.0002972696,0.0003715264,0.001109857],"category_scores_gemma":[0.0003012223,0.0001729603,0.0006741517,0.0001602708,0.0003696362,0.0002686872,0.0001724766,0.001107144,0.0002285928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005340033,"about_ca_system_score_gemma":0.0007319496,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005284023,"about_ca_topic_score_gemma":0.001320145,"domain_scores_codex":[0.9998016,0.00008328175,0.00001284796,0.0000361208,0.00002972928,0.00003644943],"domain_scores_gemma":[0.9997461,0.00003674179,0.00005368014,0.00001654914,0.00001776774,0.0001291186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5532104,0.06604856,0.04498233,0.0007940667,0.002140777,0.0004981002,0.0004640956,0.005314764,0.1472822,0.0001660989,0.002680096,0.1764184],"study_design_scores_gemma":[0.2139255,0.6678697,0.08811148,0.00003733647,0.001101507,0.0008142737,0.00007159962,0.003468501,0.02102266,0.0001340164,0.00340023,0.00004318481],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987072,0.0005700512,0.0001503042,0.00005890276,0.00001246393,0.0001262879,0.0001142173,0.00001805196,0.0002425605],"genre_scores_gemma":[0.9979463,0.0003872165,0.0004471341,0.00008409673,0.0000296328,0.0001669557,0.0005362182,0.000007632441,0.0003948727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001109857,"threshold_uncertainty_score":0.004557967,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205273215","doi":"10.1136/jitc-2021-003497","title":"Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; University of Manitoba","funders":"","keywords":"Blockade; Esophageal squamous cell carcinoma; Chemotherapy; Basal cell; Cell; Neoadjuvant therapy; Programmed cell death","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01985469544806639,"gpt":0.3174916672448145,"spread":0.2976369717967481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002832999,0.0002359618,0.0006722065,0.0002039945,0.0001630851,0.0001955106,0.0001222171,0.0001533998,0.0007797806],"category_scores_gemma":[0.0003077768,0.00009633841,0.0002803382,0.0001477264,0.0001357705,0.0001546636,0.0001612036,0.0003281329,0.0001669093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003100649,"about_ca_system_score_gemma":0.0003067688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002108041,"about_ca_topic_score_gemma":0.0009362244,"domain_scores_codex":[0.9998817,0.00004930527,0.00001328324,0.00001588331,0.00001936341,0.00002047983],"domain_scores_gemma":[0.999824,0.00004896379,0.00004479051,0.0000135704,0.00001159152,0.00005718215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06479739,0.007277807,0.3218567,0.001072459,0.0004878759,0.00492728,0.0002095321,0.004581219,0.2239946,0.0002604244,0.003634097,0.3669008],"study_design_scores_gemma":[0.005774683,0.1960343,0.6242768,0.0002470673,0.0009808758,0.01923578,0.0001917882,0.01120844,0.1227058,0.0004158196,0.01885628,0.00007241701],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945257,0.003713569,0.0004425012,0.0001212015,0.00004669086,0.0001051958,0.00008836067,0.00003067141,0.0009261134],"genre_scores_gemma":[0.9978002,0.001025595,0.0005597938,0.00006724637,0.00003942845,0.00009435762,0.0001879326,0.000003247516,0.000222255],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007797806,"threshold_uncertainty_score":0.002608597,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2800568511","doi":"10.1186/s40425-018-0328-8","title":"Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients","year":2018,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"National Institutes of Health; National Cancer Institute; Melanoma Research Alliance","keywords":"Medicine; Immunotherapy; Melanoma; CTLA-4; Biomarker; Blockade; Oncology; Ipilimumab; Immune checkpoint; Predictive value; Immunology; Immune system; Internal medicine; T cell; Cancer research; Biology; Receptor","authors":[{"name":"Priyanka B. Subrahmanyam","is_ca":true},{"name":"Zhiwan Dong","is_ca":false},{"name":"Daniel Gusenleitner","is_ca":false},{"name":"Anita Giobbie‐Hurder","is_ca":false},{"name":"Mariano Severgnini","is_ca":false},{"name":"Jun Zhou","is_ca":false},{"name":"Michael P. Manos","is_ca":false},{"name":"Lauren M. Eastman","is_ca":false},{"name":"Holden T. Maecker","is_ca":true},{"name":"F. Stephen Hodi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01553689290058551,"gpt":0.3295910235753453,"spread":0.3140541306747597,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007811796,0.0004370404,0.0005104766,0.001060538,0.0002504225,0.0007463909,0.0003025952,0.0006039413,0.001399982],"category_scores_gemma":[0.001861958,0.0001402158,0.0003610706,0.0005908129,0.0002160571,0.0004015551,0.0002981162,0.0006641921,0.0003695147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002920033,"about_ca_system_score_gemma":0.0002207143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003895249,"about_ca_topic_score_gemma":0.0004327723,"domain_scores_codex":[0.9997845,0.00005515439,0.00002183029,0.00005506379,0.0000382746,0.00004516164],"domain_scores_gemma":[0.999141,0.0003329129,0.0002538672,0.00003581701,0.0001172153,0.0001192018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001352132,0.00009645613,0.981178,0.00003469379,0.00007967751,0.0001391747,0.00004775052,0.001114459,0.004301229,0.00005769422,0.0003085634,0.01129011],"study_design_scores_gemma":[0.00005987555,0.0008679999,0.9775959,0.00003233683,0.0002680282,0.0008756082,0.0002222719,0.01347641,0.004870213,0.0005376234,0.001174277,0.00001958196],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974745,0.0008675866,0.0007059104,0.0001082083,0.00001371994,0.00002177578,0.0003146354,0.00002236633,0.000471207],"genre_scores_gemma":[0.9986456,0.0001137684,0.0005842018,0.00004208949,0.00001719065,0.00002741842,0.0003811617,0.00000402311,0.0001846476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001399982,"threshold_uncertainty_score":0.004683435,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3037575240","doi":"10.1136/jitc-2019-000467","title":"Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"University Health Network","keywords":"Medicine; Acute kidney injury; Internal medicine; Creatinine; Incidence (geometry); Kidney disease; Adverse effect; Cancer; Gastroenterology; Oncology","authors":[{"name":"Alejandro Meraz-Muñoz","is_ca":true},{"name":"Eitan Amir","is_ca":true},{"name":"Pamela Ng","is_ca":true},{"name":"Carmen Ávila-Casado","is_ca":true},{"name":"Claire Ragobar","is_ca":true},{"name":"Christopher T. Chan","is_ca":true},{"name":"S. Joseph Kim","is_ca":true},{"name":"Ron Wald","is_ca":false},{"name":"Abhijat Kitchlu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01782328958163311,"gpt":0.3066846269328215,"spread":0.2888613373511884,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008450179,0.0002072271,0.0004518241,0.0008623156,0.0002792905,0.0006812633,0.0002998807,0.0002837989,0.001183041],"category_scores_gemma":[0.002287594,0.0001567426,0.0004906537,0.001957856,0.0002221978,0.0004750664,0.000505969,0.0006416233,0.000158227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004945662,"about_ca_system_score_gemma":0.0005314468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001662187,"about_ca_topic_score_gemma":0.001598084,"domain_scores_codex":[0.9992218,0.0001419102,0.0001336667,0.0001747648,0.0001972214,0.0001306591],"domain_scores_gemma":[0.9962658,0.0003146944,0.002793632,0.0001004897,0.0002281105,0.0002971422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001205407,0.00003135574,0.9981079,0.00003247147,0.00007270139,0.00003183233,0.00000815785,0.0000343457,0.00003474446,0.00001169544,0.0001001242,0.001414138],"study_design_scores_gemma":[0.00001346287,0.00009849751,0.9988391,0.00002914737,0.00006372428,0.0004053467,0.00003565191,0.0002144125,0.00005410138,0.00003873301,0.0002049072,0.000002925],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934156,0.003739655,0.0002310562,0.000175661,0.00001643315,0.00003354745,0.001513805,0.000009272511,0.0008650023],"genre_scores_gemma":[0.9979602,0.0007872102,0.0001122625,0.00004742609,0.00004661674,0.00001954741,0.0009528587,0.000001808494,0.00007213155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001662187,"threshold_uncertainty_score":0.004468918,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2888941300","doi":"10.1186/s40425-018-0398-7","title":"Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity","year":2018,"lang":"en","type":"review","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada; Cancer Research Society","keywords":"Medicine; Immunosuppression; Immunotherapy; Perioperative; Cancer; Immune system; Surgical stress; Cancer immunotherapy; Intensive care medicine; Immunology; Bioinformatics; Surgery; Internal medicine","authors":[{"name":"Orneala Bakos","is_ca":true},{"name":"Christine Lawson","is_ca":true},{"name":"Samuel G. Rouleau","is_ca":true},{"name":"Lee‐Hwa Tai","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0573483934805771,"gpt":0.3991111887728901,"spread":0.341762795292313,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005061663,0.0005995936,0.0007388551,0.001419351,0.0002611358,0.0009789355,0.0005543993,0.001016984,0.002659985],"category_scores_gemma":[0.0007313479,0.0001683377,0.000476103,0.00103692,0.0005653266,0.001293097,0.0006284057,0.001596646,0.0007423069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003951591,"about_ca_system_score_gemma":0.0008805861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004640383,"about_ca_topic_score_gemma":0.0009602989,"domain_scores_codex":[0.9997666,0.00006001777,0.00003548699,0.00003898755,0.00007638686,0.00002244025],"domain_scores_gemma":[0.9997193,0.0001558878,0.00003863781,0.000008393839,0.00005751195,0.00002023921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007177277,0.00008383192,0.0003028581,0.02378915,0.0001294423,0.0002137732,0.0001080845,0.0003171447,0.002976431,0.006855274,0.02641338,0.9387389],"study_design_scores_gemma":[0.00001653207,0.0001550683,0.001117051,0.006234951,0.0001354886,0.00197691,0.0001354993,0.0001175541,0.0009884243,0.004106207,0.9849978,0.00001850431],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001599286,0.9981206,0.0001479842,0.0004270484,0.0002915855,0.000003847897,0.000007280428,0.000005031149,0.0008367519],"genre_scores_gemma":[0.001356471,0.9974461,0.0001922801,0.0003016999,0.0002733738,0.00000633987,0.0000121343,0.000001151726,0.0004105075],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002659985,"threshold_uncertainty_score":0.008898497,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2973724679","doi":"10.1186/s40425-019-0734-6","title":"Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":187,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Hospital Foundation","funders":"Qatar National Research Fund; Istituto Oncologico Veneto; Fondazione Italiana per la Ricerca sul Cancro; Università degli Studi di Verona; Università Cattolica del Sacro Cuore; Università degli Studi di Padova; Cancer Research Institute; Fondazione Italiana per la ricerca sulle Malattie del Pancreas; EuroNanoMed III; Associazione Italiana per la Ricerca sul Cancro; Agence Nationale de la Recherche","keywords":"CD14; Myeloid-derived Suppressor Cell; Immunosuppression; Medicine; Immune system; Cancer research; Myeloid; Flow cytometry; STAT3; Immunology; CD16; Suppressor; Biology; Internal medicine; Cancer; Apoptosis","authors":[{"name":"Rosalinda Trovato","is_ca":false},{"name":"Alessandra Fiore","is_ca":false},{"name":"S Sartori","is_ca":false},{"name":"Stefania Canè","is_ca":false},{"name":"Rosalba Giugno","is_ca":false},{"name":"Luciano Cascione","is_ca":false},{"name":"Salvatore Paiella","is_ca":false},{"name":"Roberto Salvia","is_ca":false},{"name":"Francesco De Sanctis","is_ca":false},{"name":"Ornella Poffe","is_ca":false},{"name":"Cristina Anselmi","is_ca":false},{"name":"Francesca Hofer","is_ca":false},{"name":"Silvia Sartoris","is_ca":false},{"name":"Geny Piro","is_ca":false},{"name":"Carmine Carbone","is_ca":false},{"name":"Rita T. Lawlor","is_ca":true},{"name":"Samantha Solito","is_ca":false},{"name":"Laura Pinton","is_ca":false},{"name":"Susanna Mandruzzato","is_ca":false},{"name":"Claudio Bassi","is_ca":false},{"name":"Aldo Scarpa","is_ca":true},{"name":"Vincenzo Bronte","is_ca":false},{"name":"Stefano Ugel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005649180257663867,"gpt":0.2396133105434502,"spread":0.2339641302857864,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001593937,0.0001573471,0.0002677178,0.0003338916,0.0002777297,0.0002677436,0.0001039768,0.000156826,0.0008966471],"category_scores_gemma":[0.0003649975,0.0001016799,0.0001477707,0.0003874863,0.0001485569,0.0001602244,0.000161777,0.0002850268,0.0001227867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001634558,"about_ca_system_score_gemma":0.0001614017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002815204,"about_ca_topic_score_gemma":0.000467815,"domain_scores_codex":[0.999898,0.00002161833,0.00001056511,0.00002677469,0.00002149285,0.00002163367],"domain_scores_gemma":[0.9998011,0.00004446086,0.00007893802,0.00001360108,0.00001719196,0.00004483684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001590499,0.00007423728,0.9706147,0.0000331304,0.00003632903,0.0008964043,0.0001295913,0.0001085797,0.01646032,0.00004390082,0.0002313752,0.009780863],"study_design_scores_gemma":[0.00003205625,0.0003790746,0.9939194,0.000007421225,0.00004894852,0.00278322,0.0001201111,0.0003185787,0.001734371,0.00006419238,0.0005888479,0.000003705038],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992496,0.0003563853,0.00006521939,0.00002292435,0.000002664174,0.000004112612,0.00007780693,0.000005652561,0.0002156422],"genre_scores_gemma":[0.9996713,0.00008655072,0.00005716956,0.00001081395,0.000006333245,0.000003417824,0.000107237,0.000001171724,0.00005583825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008966471,"threshold_uncertainty_score":0.002999544,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2895870246","doi":"10.1186/s40425-018-0420-0","title":"Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study","year":2018,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University of Calgary; BC Cancer Agency","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Medicine; Pazopanib; Nivolumab; Sunitinib; Renal cell carcinoma; Tolerability; Discontinuation; Adverse effect; Internal medicine; Clinical endpoint; Oncology; Peripheral edema; Urology; Clinical trial; Cancer; Immunotherapy","authors":[{"name":"Asim Amin","is_ca":false},{"name":"Elizabeth R. Plimack","is_ca":false},{"name":"Marc S. Ernstoff","is_ca":false},{"name":"Lionel D. Lewis","is_ca":false},{"name":"Todd M. Bauer","is_ca":false},{"name":"David F. McDermott","is_ca":false},{"name":"Michael A. Carducci","is_ca":false},{"name":"Christian Kollmannsberger","is_ca":true},{"name":"Brian I. Rini","is_ca":false},{"name":"Daniel Y.C. Heng","is_ca":true},{"name":"Jennifer J. Knox","is_ca":true},{"name":"Martin H. Voss","is_ca":false},{"name":"Jennifer L. Spratlin","is_ca":true},{"name":"Elmer Berghorn","is_ca":false},{"name":"Lingfeng Yang","is_ca":false},{"name":"Hans J. Hammers","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02981774737536692,"gpt":0.3328356411832563,"spread":0.3030178938078893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002165051,0.0006600596,0.001325783,0.0002811516,0.0002796844,0.0008126523,0.0006446652,0.0008794177,0.001381268],"category_scores_gemma":[0.001002386,0.0002611131,0.001217238,0.0002987333,0.0003654745,0.0003725304,0.0002787428,0.00135727,0.0003186119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008155921,"about_ca_system_score_gemma":0.0009339249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007478277,"about_ca_topic_score_gemma":0.001728797,"domain_scores_codex":[0.9994805,0.0002763725,0.000031248,0.00007941642,0.00009427498,0.00003819541],"domain_scores_gemma":[0.999163,0.0001689931,0.0002556403,0.00007108217,0.00006467837,0.0002765834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6551614,0.02702121,0.07376736,0.001513091,0.008250867,0.0005173732,0.0002926743,0.004881903,0.05189932,0.0001606336,0.005135499,0.1713988],"study_design_scores_gemma":[0.3618235,0.4472198,0.1551079,0.0001160684,0.005325646,0.001260611,0.00007104487,0.004820218,0.01470851,0.0001572928,0.009310246,0.00007915191],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945318,0.003194704,0.0001825689,0.0001342113,0.00003198144,0.000256391,0.0005789186,0.00002778749,0.00106171],"genre_scores_gemma":[0.996309,0.001213095,0.000297936,0.0002469571,0.00006983631,0.0001692546,0.001124192,0.00000982683,0.0005599282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002165051,"threshold_uncertainty_score":0.01144999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3011282656","doi":"10.1136/jitc-2019-000282","title":"Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":175,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Vanderbilt Institute of Chemical Biology, School of Medicine, Vanderbilt University; Division of Chemical, Bioengineering, Environmental, and Transport Systems; National Institute of Diabetes and Digestive and Kidney Diseases; American Cancer Society; Vanderbilt University Medical Center; Vanderbilt University; Stand Up To Cancer; National Cancer Institute; Entertainment Industry Foundation; National Science Foundation; Canadian Institutes of Health Research; Alex's Lemonade Stand Foundation for Childhood Cancer; Vanderbilt Digestive Diseases Research Center, Vanderbilt University Medical Center; American Association for Cancer Research; National Institutes of Health","keywords":"Sting; Stimulator of interferon genes; Cancer research; Neuroblastoma; Immunogenic cell death; Immunotherapy; CD8; Programmed cell death; T cell; Cancer immunotherapy; Medicine; Apoptosis; Blockade; Interferon; Immune checkpoint; Immunogenicity; Immune system; Cell cycle checkpoint; Immunology; Biology; Cell cycle; Cell culture; Cancer; Innate immune system; Receptor; Internal medicine","authors":[{"name":"Lihong Wang-Bishop","is_ca":false},{"name":"Mohamed Wehbe","is_ca":false},{"name":"Daniel Shae","is_ca":false},{"name":"Jamaal L. James","is_ca":false},{"name":"Benjamin C. Hacker","is_ca":false},{"name":"Kyle M. Garland","is_ca":false},{"name":"Plamen P. Chistov","is_ca":false},{"name":"Marjan Rafat","is_ca":false},{"name":"Justin M. Balko","is_ca":false},{"name":"John T. Wilson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0229599501272848,"gpt":0.3284229721530053,"spread":0.3054630220257205,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009119653,0.0001942609,0.0001356352,0.00008292876,0.00005589159,0.0001067944,0.00008375953,0.0001284881,0.0007600391],"category_scores_gemma":[0.00004740725,0.00005374381,0.0001408437,0.00006277524,0.000105496,0.0001167619,0.00009707865,0.0002961578,0.000118506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000174296,"about_ca_system_score_gemma":0.000110374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001952548,"about_ca_topic_score_gemma":0.0004032374,"domain_scores_codex":[0.9999471,0.000007923666,0.000004972359,0.000009480077,0.00001929485,0.00001118835],"domain_scores_gemma":[0.999972,0.000006161972,0.000008365812,0.000003180617,0.000004280413,0.000005979284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002775141,0.00001042211,0.00005337921,0.00002190254,9.771289e-7,0.00001260421,0.000006595435,0.00004992805,0.9993439,0.00002582885,0.000008987833,0.0004376928],"study_design_scores_gemma":[0.000008440739,0.000279557,0.001103342,0.000003681063,0.000004448013,0.0000790464,0.000008216402,0.0006397775,0.9971385,0.00001496439,0.0007190606,0.000001066222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959387,0.0008827776,0.002209852,0.00002879471,0.00001238909,0.00002614226,0.00009821655,0.00002172952,0.000781556],"genre_scores_gemma":[0.996296,0.0006614901,0.002038981,0.00002145005,0.000006368833,0.00003279568,0.0001155133,0.000004647852,0.0008228068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007600391,"threshold_uncertainty_score":0.002542615,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2886177168","doi":"10.1186/s40425-018-0381-3","title":"White paper on microbial anti-cancer therapy and prevention","year":2018,"lang":"en","type":"review","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":167,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovative Targeting Solutions (Canada)","funders":"National Cancer Institute","keywords":"Cancer therapy; Oncolytic virus; Medicine; Cancer; Cancer treatment; Commercialization; Intensive care medicine; Business; Internal medicine","authors":[{"name":"Neil S. Forbes","is_ca":false},{"name":"Robert S. Coffin","is_ca":false},{"name":"Liang Deng","is_ca":false},{"name":"Laura Evgin","is_ca":false},{"name":"Steve Fiering","is_ca":false},{"name":"Matthew J. Giacalone","is_ca":false},{"name":"Claudia Gravekamp","is_ca":false},{"name":"James L. Gulley","is_ca":false},{"name":"Hal Gunn","is_ca":true},{"name":"Robert M. Hoffman","is_ca":false},{"name":"Balveen Kaur","is_ca":false},{"name":"Ke Liu","is_ca":false},{"name":"H. Kim Lyerly","is_ca":false},{"name":"Ariel E. Marciscano","is_ca":false},{"name":"Eddie Moradian","is_ca":false},{"name":"Sheryl Ruppel","is_ca":false},{"name":"Daniel A. Saltzman","is_ca":false},{"name":"Peter Tattersall","is_ca":false},{"name":"Steve H. Thorne","is_ca":false},{"name":"Richard G. Vile","is_ca":false},{"name":"Halle Huihong Zhang","is_ca":false},{"name":"Shibin Zhou","is_ca":false},{"name":"Grant McFadden","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0546215324629758,"gpt":0.4213625898970199,"spread":0.3667410574340441,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009317319,0.0008499472,0.0007544958,0.00150729,0.0005458731,0.001477806,0.0009360973,0.002226074,0.01082265],"category_scores_gemma":[0.001691527,0.0002793968,0.0005953086,0.001197546,0.0008179098,0.002342543,0.001071712,0.004620231,0.006915987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008604115,"about_ca_system_score_gemma":0.001488112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009401732,"about_ca_topic_score_gemma":0.001612148,"domain_scores_codex":[0.999513,0.00007161462,0.00005160688,0.00008059455,0.0002363365,0.00004681804],"domain_scores_gemma":[0.9994078,0.0002300136,0.00005551369,0.00002681621,0.0001950784,0.00008484014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000609219,0.0000693669,0.0001017354,0.003933858,0.00003818326,0.0002238342,0.00007557344,0.0001714646,0.001201868,0.01519898,0.3486821,0.6302421],"study_design_scores_gemma":[0.000003953655,0.00001558951,0.0000612872,0.0004830108,0.000006839381,0.0002345839,0.000008662368,0.00001112911,0.0001562624,0.0008136331,0.9982015,0.000003497511],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001308202,0.9672268,0.0005186781,0.005450151,0.01555325,0.00002850252,0.00006036021,0.00003002432,0.0110014],"genre_scores_gemma":[0.001404519,0.9699251,0.0005501241,0.006802144,0.004806436,0.00002909367,0.0001088526,0.00001648003,0.01635722],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01082265,"threshold_uncertainty_score":0.03620541,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214685750","doi":"10.1136/jitc-2021-003776","title":"Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation; American Society of Clinical Oncology; Novartis","keywords":"Medicine; Adverse effect; Dosing; Internal medicine; Oncology; Cancer; Gastroenterology","authors":[{"name":"Patrick Schöffski","is_ca":false},{"name":"Daniel Shao-Weng Tan","is_ca":false},{"name":"Miguel Martín","is_ca":false},{"name":"María Ochoa-de-Olza","is_ca":false},{"name":"John Sarantopoulos","is_ca":false},{"name":"Richard D. Carvajal","is_ca":false},{"name":"Chrisann Kyi","is_ca":false},{"name":"Taito Esaki","is_ca":false},{"name":"Amy Prawira","is_ca":true},{"name":"Wallace Akerley","is_ca":false},{"name":"Filippo de Braud","is_ca":false},{"name":"Rina Hui","is_ca":false},{"name":"Tian Zhang","is_ca":false},{"name":"Ross A. Soo","is_ca":false},{"name":"Michela Maur","is_ca":false},{"name":"Andrew Weickhardt","is_ca":false},{"name":"Jürgen Krauß","is_ca":false},{"name":"Barbara Deschler-Baier","is_ca":false},{"name":"Allen S. Lau","is_ca":false},{"name":"Tanay S. Samant","is_ca":false},{"name":"Tyler A. Longmire","is_ca":false},{"name":"Niladri Roy Chowdhury","is_ca":false},{"name":"Catherine Sabatos-Peyton","is_ca":false},{"name":"Nidhi Patel","is_ca":false},{"name":"Radha Ramesh","is_ca":false},{"name":"Tiancen Hu","is_ca":false},{"name":"Ana Carion","is_ca":false},{"name":"Daniel Gusenleitner","is_ca":false},{"name":"Padmaja Yerramilli-Rao","is_ca":false},{"name":"Vasileios Askoxylakis","is_ca":false},{"name":"Eunice L. Kwak","is_ca":false},{"name":"David S. Hong","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01189213994870178,"gpt":0.3023932276310027,"spread":0.290501087682301,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009571904,0.001013658,0.001559323,0.0002941837,0.0002695521,0.0005491056,0.0004365322,0.0004970749,0.00208862],"category_scores_gemma":[0.0004619437,0.0004164036,0.0007233756,0.0002435636,0.0005746095,0.0004173156,0.0002569856,0.001565295,0.0004428496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007178919,"about_ca_system_score_gemma":0.001098195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006390285,"about_ca_topic_score_gemma":0.001465065,"domain_scores_codex":[0.9997525,0.0000999921,0.00001411213,0.00005626267,0.00002459186,0.00005267691],"domain_scores_gemma":[0.9996992,0.00004029127,0.00004963758,0.00002282265,0.00001415266,0.0001737646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5396656,0.0902372,0.01927827,0.0007275066,0.0009998215,0.0004087138,0.0004474836,0.005281021,0.1379805,0.0005094574,0.00388386,0.2005805],"study_design_scores_gemma":[0.3622696,0.6000337,0.0208798,0.0000348921,0.0004618463,0.0003883765,0.00008270575,0.002112482,0.009741401,0.0002668478,0.003704227,0.0000240935],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949657,0.001281537,0.0005102415,0.0001804735,0.00005607693,0.00150005,0.0003476118,0.00005391713,0.001104231],"genre_scores_gemma":[0.9947956,0.0008712543,0.001193973,0.0002879349,0.00006730622,0.001068825,0.0007048618,0.000009665489,0.001000565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00208862,"threshold_uncertainty_score":0.006987095,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981595408","doi":"10.1186/s40425-019-0762-2","title":"Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Pediatric Oncology Group","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; EMD Serono; Eisai; Servier; Amgen; Pfizer; Daiichi Sankyo Europe; Eli Lilly and Company; Eurostars; GlaxoSmithKline","keywords":"Medicine; T cell; Immunology; Fludarabine; Tumor microenvironment; Progressive disease; Synovial sarcoma; Cytotoxic T cell; Immune system; Cancer research; Internal medicine; Pathology; Sarcoma; Biology; Disease; Chemotherapy","authors":[{"name":"Indu Ramachandran","is_ca":false},{"name":"Daniel E. Lowther","is_ca":false},{"name":"Rebecca Dryer-Minnerly","is_ca":false},{"name":"Ruoxi Wang","is_ca":false},{"name":"Svetlana Fayngerts","is_ca":false},{"name":"Daniel Álvarez Núñez","is_ca":false},{"name":"Gareth Betts","is_ca":false},{"name":"Natalie Bath","is_ca":false},{"name":"Alex J. Tipping","is_ca":false},{"name":"Luca Melchiori","is_ca":false},{"name":"Jean-Marc Navenot","is_ca":false},{"name":"John Glod","is_ca":false},{"name":"Crystal L. Mackall","is_ca":false},{"name":"Sandra P. D’Angelo","is_ca":false},{"name":"Dejka M. Araujo","is_ca":false},{"name":"Warren Chow","is_ca":false},{"name":"George D. Demetri","is_ca":false},{"name":"Mihaela Druta","is_ca":false},{"name":"Brian Andrew Van Tine","is_ca":false},{"name":"Stephan A. Grupp","is_ca":true},{"name":"Albiruni R. Abdul Razak","is_ca":true},{"name":"Breelyn A. Wilky","is_ca":false},{"name":"Malini Iyengar","is_ca":false},{"name":"Trupti Trivedi","is_ca":false},{"name":"Erin Van Winkle","is_ca":false},{"name":"Karen Chagin","is_ca":false},{"name":"Rafael G. Amado","is_ca":false},{"name":"Gwendolyn K. Binder","is_ca":false},{"name":"Samik Basu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01853585997131978,"gpt":0.3255511113769634,"spread":0.3070152514056436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002162915,0.0002297079,0.000334205,0.0001393574,0.0001005954,0.0001646377,0.000107882,0.0001567124,0.0006482766],"category_scores_gemma":[0.0001879925,0.00009354417,0.0001839341,0.0000988559,0.0002139918,0.0001493044,0.000157569,0.0004849665,0.0001713614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001593137,"about_ca_system_score_gemma":0.0001583631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002845144,"about_ca_topic_score_gemma":0.0004487594,"domain_scores_codex":[0.9998747,0.0000295208,0.000009058523,0.00002418354,0.00002479401,0.00003766194],"domain_scores_gemma":[0.9998811,0.0000235242,0.00002698668,0.00001597789,0.000006404632,0.00004592997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01151073,0.002583775,0.01462436,0.0001038319,0.00005811337,0.0005418268,0.0001952963,0.001377159,0.9300939,0.0001034563,0.0004521825,0.0383555],"study_design_scores_gemma":[0.001798701,0.1430706,0.2194488,0.00003221348,0.0003253393,0.003881176,0.0004405497,0.006317065,0.6208394,0.000261326,0.003554866,0.00002982566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994195,0.0001482188,0.0001503087,0.00001163553,0.000005415706,0.00001385424,0.00002822779,0.000009555647,0.0002134153],"genre_scores_gemma":[0.9994355,0.00007825813,0.0001108359,0.00002020632,0.000008473102,0.00001793552,0.0000930958,0.000002746701,0.0002329143],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006482766,"threshold_uncertainty_score":0.002168775,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3006887831","doi":"10.1136/jitc-2019-000186","title":"On the mechanism of anti-CD39 immune checkpoint therapy","year":2020,"lang":"en","type":"review","venue":"Journal for ImmunoTherapy of Cancer","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":140,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Institute of Cancer Research; Terry Fox Research Institute","keywords":"Adenosinergic; Medicine; Immunotherapy; Adenosine; Mechanism of action; Cancer immunotherapy; Regulator; Adenosine receptor; Immune system; Targeted therapy; Pharmacology; Immunology; Cancer; Receptor; Cancer research; Biology; Internal medicine; In vitro; Gene","authors":[{"name":"David Allard","is_ca":true},{"name":"Bertrand Allard","is_ca":true},{"name":"John Stagg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03803198016739658,"gpt":0.3450691634505271,"spread":0.3070371832831305,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003608311,0.0006060659,0.0008515072,0.001174823,0.0002288612,0.0007839077,0.0007243793,0.0009840108,0.003098427],"category_scores_gemma":[0.0002532121,0.0002158819,0.0004138066,0.0008729967,0.00036333,0.001002896,0.0004464107,0.002039107,0.001972919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006383762,"about_ca_system_score_gemma":0.0007275327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004806774,"about_ca_topic_score_gemma":0.001003066,"domain_scores_codex":[0.9998941,0.00001791077,0.00001194278,0.00001944886,0.000040846,0.00001568902],"domain_scores_gemma":[0.9999284,0.00002913294,0.00001029269,0.000002514641,0.00002072355,0.000008961619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001327019,0.00009351828,0.0001071088,0.01072786,0.00007022984,0.0003903353,0.00006137929,0.0006027704,0.005949179,0.01166539,0.04247743,0.9277222],"study_design_scores_gemma":[0.00002962366,0.0001255876,0.0004557962,0.001821868,0.00004936535,0.001056686,0.00002380337,0.0001297576,0.0009351724,0.002652447,0.9927083,0.0000115784],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003038759,0.9959925,0.0002032921,0.0005548787,0.0005928222,0.000009459982,0.00002237302,0.0000100998,0.002310715],"genre_scores_gemma":[0.001382162,0.9958034,0.0001686344,0.0005921319,0.0003315791,0.0000135506,0.00003057119,0.000001643034,0.001676356],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003098427,"threshold_uncertainty_score":0.01036525,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134221665","doi":"10.1136/jitc-2020-001901","title":"Considerations for treatment duration in responders to immune checkpoint inhibitors","year":2021,"lang":"en","type":"review","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; Society for Immunotherapy of Cancer","keywords":"Medicine; Immunotherapy; Clinical trial; Limiting; Oncology; Cancer; Internal medicine; Intensive care medicine","authors":[{"name":"Thomas U. Marron","is_ca":false},{"name":"Aideen E. Ryan","is_ca":false},{"name":"Sangeetha M. Reddy","is_ca":false},{"name":"Sabina Kaczanowska","is_ca":false},{"name":"Rania H. Younis","is_ca":false},{"name":"Dipti Thakkar","is_ca":false},{"name":"Jiajia Zhang","is_ca":false},{"name":"Todd Bartkowiak","is_ca":false},{"name":"Rachel Howard","is_ca":false},{"name":"Kristin G. Anderson","is_ca":false},{"name":"Daniel J. Olson","is_ca":false},{"name":"Abdul Rafeh Naqash","is_ca":false},{"name":"Ravi B. Patel","is_ca":false},{"name":"Esha Sachdev","is_ca":false},{"name":"María E. Rodríguez-Ruiz","is_ca":false},{"name":"Michal Sheffer","is_ca":false},{"name":"S. Church","is_ca":false},{"name":"Christopher A. Fuhrman","is_ca":false},{"name":"Abigail E. Overacre-Delgoffe","is_ca":false},{"name":"Rosa Nguyen","is_ca":true},{"name":"Vaia Florou","is_ca":false},{"name":"Jessica E. Thaxton","is_ca":false},{"name":"David H. Aggen","is_ca":false},{"name":"Jennifer L. Guerriero","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08771796083704402,"gpt":0.4250182670291007,"spread":0.3373003061920567,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002692412,0.000469621,0.002011491,0.000939242,0.0002325234,0.001046166,0.001192891,0.001485522,0.002692334],"category_scores_gemma":[0.004225287,0.0002080159,0.0009095533,0.0008001804,0.0004926057,0.001196635,0.0004738642,0.003002536,0.0009987145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000932007,"about_ca_system_score_gemma":0.001137206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001039412,"about_ca_topic_score_gemma":0.00242716,"domain_scores_codex":[0.9991404,0.0003058848,0.0002198808,0.00009364568,0.0001897956,0.00005046355],"domain_scores_gemma":[0.9979666,0.001448166,0.000265276,0.00002598727,0.0002342542,0.00005972056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004398002,0.00006681093,0.0003649683,0.0203398,0.0001643927,0.0001218995,0.00008719358,0.0003286767,0.0008076841,0.004406571,0.03146644,0.9414058],"study_design_scores_gemma":[0.000389273,0.0004678788,0.003717001,0.02800214,0.0005416414,0.001712398,0.0001624867,0.0002502809,0.0005970799,0.00555445,0.9585628,0.00004261529],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002785665,0.9968124,0.0001333671,0.001512616,0.000327066,0.00001344823,0.00002832895,0.000005060198,0.0008890941],"genre_scores_gemma":[0.004062566,0.9914525,0.0006330766,0.002339109,0.000568488,0.00006238977,0.00007373998,0.000005527862,0.0008025974],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002692412,"threshold_uncertainty_score":0.01423901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3034105569","doi":"10.1136/jitc-2019-000266","title":"Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":123,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Israel Science Foundation; Hebrew University of Jerusalem; Centre in Green Chemistry and Catalysis; Israel Cancer Research Fund","keywords":"TIGIT; Cancer research; Medicine; Computational biology; Computer science; Internal medicine; Biology; Immunotherapy; Cancer","authors":[{"name":"Adi Reches","is_ca":false},{"name":"Yael Ophir","is_ca":false},{"name":"Natan Stein","is_ca":false},{"name":"Inbal Kol","is_ca":false},{"name":"Batya Isaacson","is_ca":false},{"name":"Yoav Charpak‐Amikam","is_ca":false},{"name":"Afek Elnekave","is_ca":false},{"name":"Pinchas Tsukerman","is_ca":false},{"name":"Paola Kučan Brlić","is_ca":false},{"name":"Barbara Seliger","is_ca":false},{"name":"Stipan Jonjić","is_ca":false},{"name":"Ofer Mandelboim","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02615766639445402,"gpt":0.2801342962558834,"spread":0.2539766298614293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001411746,0.0004896099,0.0002553629,0.0002449576,0.0001997752,0.0003145492,0.0004451576,0.0005762527,0.001294115],"category_scores_gemma":[0.0001307132,0.0001023538,0.0002672366,0.0001829719,0.0002070051,0.0002796607,0.0003443698,0.0004782847,0.0004008645],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007537367,"about_ca_system_score_gemma":0.0003172498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004018714,"about_ca_topic_score_gemma":0.0006561023,"domain_scores_codex":[0.9998764,0.00002593747,0.000009098608,0.00002767652,0.00003041414,0.00003054217],"domain_scores_gemma":[0.9999435,0.000006871097,0.00001379764,0.000005418147,0.000009557421,0.00002079331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009476604,0.00005377868,0.0004774363,0.00007958236,0.00001625592,0.0001806688,0.0000104912,0.0004077471,0.9904517,0.0003805124,0.0003012839,0.00754573],"study_design_scores_gemma":[0.00008711845,0.001155364,0.002799146,0.00002482104,0.00006134244,0.004408065,0.00002176796,0.002745293,0.9613219,0.000237297,0.02712096,0.00001695717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9436474,0.02334405,0.0196317,0.0009278712,0.0001932501,0.000181974,0.0004138202,0.0003823395,0.01127757],"genre_scores_gemma":[0.9661483,0.005003535,0.02089062,0.0004711251,0.00006871182,0.0001122523,0.001054438,0.0000333241,0.006217562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001294115,"threshold_uncertainty_score":0.005468726,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3091948129","doi":"10.1136/jitc-2020-001006","title":"Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Amgen","keywords":"Pembrolizumab; Medicine; Rash; Maculopapular rash; Internal medicine; Adverse effect; Refractory (planetary science); Gastroenterology; Lung cancer; Oncology; Cancer; Immunotherapy","authors":[{"name":"Albiruni RA Razak","is_ca":true},{"name":"James M. Cleary","is_ca":false},{"name":"Víctor Moreno","is_ca":false},{"name":"Michael Boyer","is_ca":false},{"name":"William J. Edenfield","is_ca":false},{"name":"Jeanne Tie","is_ca":false},{"name":"R. Donald Harvey","is_ca":false},{"name":"Annemie Rutten","is_ca":false},{"name":"Manish A. Shah","is_ca":false},{"name":"Anthony J. Olszanski","is_ca":false},{"name":"Dirk Jäger","is_ca":false},{"name":"Nehal J. Lakhani","is_ca":false},{"name":"David P. Ryan","is_ca":false},{"name":"Erik Rasmussen","is_ca":false},{"name":"Gloria Juan","is_ca":false},{"name":"Hansen Wong","is_ca":false},{"name":"Neelesh Soman","is_ca":false},{"name":"Marie-Anne Damiette Smit","is_ca":false},{"name":"Dirk Nagorsen","is_ca":false},{"name":"Kyriakos P. Papadopoulos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01364674565156922,"gpt":0.3253575315053835,"spread":0.3117107858538143,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007423221,0.0003793298,0.0007753718,0.0002022553,0.0001860737,0.0003307384,0.0001904671,0.0003719263,0.0005312713],"category_scores_gemma":[0.00107386,0.0001477018,0.0003765133,0.000187501,0.0002362263,0.0002692342,0.000150802,0.0006616451,0.0002043572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004316924,"about_ca_system_score_gemma":0.0003499587,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000232909,"about_ca_topic_score_gemma":0.0004640865,"domain_scores_codex":[0.9996767,0.0001495353,0.00003771954,0.00004642782,0.00006222697,0.00002736865],"domain_scores_gemma":[0.9994065,0.0001505102,0.0002587148,0.00001961094,0.0000357051,0.0001289006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1908148,0.007791603,0.3270181,0.001059862,0.001802539,0.00126968,0.0004473838,0.002938863,0.06911827,0.0001524449,0.002667608,0.394919],"study_design_scores_gemma":[0.03709998,0.3678747,0.5473741,0.000264807,0.002037343,0.006173404,0.0001971096,0.00597829,0.02211607,0.00019542,0.01064145,0.00004746393],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950577,0.003918338,0.0002082732,0.0001196974,0.00001610498,0.0000540245,0.00009178787,0.00001366536,0.0005203873],"genre_scores_gemma":[0.9983734,0.0008582794,0.0002650518,0.0001374625,0.00004601256,0.00005079437,0.0001490992,0.0000022308,0.0001175678],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007753718,"threshold_uncertainty_score":0.0039258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2946884236","doi":"10.1186/s40425-019-0575-3","title":"CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"Roche Innovation Center Zurich; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Sociedad Española de Oncología Médica; Cancer Research UK; Wellcome Trust","keywords":"Medicine; Colorectal cancer; Immunotherapy; Cancer immunotherapy; Organoid; Bispecific antibody; Cancer research; Antibody; Immunology; Cancer; Monoclonal antibody; Biology; Internal medicine; Genetics","authors":[{"name":"Reyes Gonzalez-Exposito","is_ca":true},{"name":"Maria Semiannikova","is_ca":true},{"name":"B Griffiths","is_ca":true},{"name":"Khurum Khan","is_ca":false},{"name":"Louise J. Barber","is_ca":true},{"name":"Andrew Woolston","is_ca":true},{"name":"Georgia Spain","is_ca":true},{"name":"Katharina von Loga","is_ca":true},{"name":"Benjamin Challoner","is_ca":true},{"name":"Radhika Patel","is_ca":true},{"name":"Michael Ranes","is_ca":true},{"name":"Amanda Swain","is_ca":true},{"name":"Janet Thomas","is_ca":false},{"name":"Annette Bryant","is_ca":false},{"name":"Claire Saffery","is_ca":false},{"name":"Nicos Fotiadis","is_ca":false},{"name":"Sebastian Guettler","is_ca":true},{"name":"David Mansfield","is_ca":true},{"name":"Alan Melcher","is_ca":true},{"name":"Thomas Powles","is_ca":false},{"name":"Sheela Rao","is_ca":false},{"name":"David Watkins","is_ca":false},{"name":"Ian Chau","is_ca":false},{"name":"Nik Matthews","is_ca":true},{"name":"Fredrik Wållberg","is_ca":true},{"name":"Naureen Starling","is_ca":false},{"name":"David Cunningham","is_ca":false},{"name":"Marco Gerlinger","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01788892149129567,"gpt":0.3402455607845739,"spread":0.3223566392932782,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009038764,0.0001342065,0.0001758768,0.0001880463,0.0001388593,0.0003213581,0.0001043116,0.0001896302,0.001429497],"category_scores_gemma":[0.0001665213,0.0001533631,0.0002113851,0.0001472886,0.0001354048,0.0001437351,0.0001933531,0.0005402695,0.0003713982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002455277,"about_ca_system_score_gemma":0.0001369629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001639172,"about_ca_topic_score_gemma":0.001578892,"domain_scores_codex":[0.9998549,0.00001907308,0.00001694398,0.00003283759,0.00002938298,0.00004678606],"domain_scores_gemma":[0.999855,0.00003332749,0.00002211706,0.00002408033,0.00001362602,0.00005179388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002059752,0.0000432617,0.00170704,0.00001017187,0.000005815991,0.0001128101,0.00004516414,0.00007858456,0.9968862,0.0000965888,0.00006534447,0.0007430413],"study_design_scores_gemma":[0.00005271381,0.001224243,0.07406849,0.000006162948,0.0000442749,0.002352367,0.0002612721,0.003302259,0.9153796,0.0001152234,0.00317913,0.00001431393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985973,0.0001079193,0.0004605256,0.00002031057,0.000004868196,0.00001248773,0.0002029587,0.00001942608,0.0005741684],"genre_scores_gemma":[0.99839,0.00007388905,0.0003943357,0.00002426356,0.000002380659,0.00001886025,0.0004366014,0.00001022469,0.000649485],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001639172,"threshold_uncertainty_score":0.00478214,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205349336","doi":"10.1136/jitc-2021-003779","title":"Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SKiN Health","funders":"Cancer Prevention and Research Institute of Texas","keywords":"Medicine; Lung cancer; Internal medicine; Adverse effect; Cancer; Retrospective cohort study; Adverse Event Reporting System; Antibiotics; Pharmacovigilance; Logistic regression; Oncology","authors":[{"name":"Ying Jing","is_ca":false},{"name":"Xue Chen","is_ca":false},{"name":"Kunyan Li","is_ca":false},{"name":"Yaoming Liu","is_ca":false},{"name":"Zhao Zhang","is_ca":false},{"name":"Yiqing Chen","is_ca":false},{"name":"Yuan Liu","is_ca":false},{"name":"Yushu Wang","is_ca":false},{"name":"Steven H. Lin","is_ca":false},{"name":"Lixia Diao","is_ca":false},{"name":"Jing Wang","is_ca":false},{"name":"Yanyan Lou","is_ca":false},{"name":"Douglas B. Johnson","is_ca":true},{"name":"Xiang Chen","is_ca":true},{"name":"Hong Liu","is_ca":false},{"name":"Leng Han","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008027828496329797,"gpt":0.2762625650620914,"spread":0.2682347365657616,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001644702,0.0001923806,0.0004628899,0.0007402164,0.0003938746,0.0006145601,0.0003402428,0.0003746908,0.001840828],"category_scores_gemma":[0.006886246,0.000153389,0.0009023043,0.001576579,0.0002759339,0.0003764995,0.0004222661,0.000903118,0.0001289691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003909421,"about_ca_system_score_gemma":0.0005551595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001344695,"about_ca_topic_score_gemma":0.001449296,"domain_scores_codex":[0.9974251,0.0006776547,0.0005394096,0.0005629679,0.0005086816,0.0002862308],"domain_scores_gemma":[0.9891564,0.002297461,0.007070017,0.0004688014,0.0005873109,0.0004200058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001739621,0.00002127757,0.9969657,0.00005703244,0.0001349952,0.00005908583,0.00001785822,0.00005981915,0.00008066461,0.00002649148,0.0001509588,0.002252225],"study_design_scores_gemma":[0.00001524648,0.0001429409,0.997403,0.00003487949,0.0001407677,0.0006159277,0.00007761545,0.0003854079,0.000144843,0.00009285226,0.0009406875,0.000005854787],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912447,0.004578075,0.0008776297,0.0003486475,0.00005197027,0.00004503764,0.001675438,0.00001329808,0.001165153],"genre_scores_gemma":[0.9981779,0.0005026062,0.0002961638,0.0001322321,0.00005030385,0.0000287845,0.0006816708,0.000004070377,0.0001262048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001840828,"threshold_uncertainty_score":0.008698106,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1517732299","doi":"10.1186/s40425-015-0066-0","title":"Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation","year":2015,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Ipilimumab; Medicine; Liver transplantation; Melanoma; Transplantation; Metastatic melanoma; Oncology; Internal medicine; Cancer; Immunotherapy; Cancer research","authors":[{"name":"Rita E Morales","is_ca":true},{"name":"Alexander N. Shoushtari","is_ca":false},{"name":"Michelle M. Walsh","is_ca":false},{"name":"Priya Grewal","is_ca":false},{"name":"Evan J. Lipson","is_ca":false},{"name":"Richard D. Carvajal","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02023009573251548,"gpt":0.3295934070659579,"spread":0.3093633113334424,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008877647,0.0001517069,0.0004661737,0.0002043925,0.0002504204,0.0003612381,0.0001867806,0.0002740802,0.0007859726],"category_scores_gemma":[0.001784798,0.00004793559,0.0003523061,0.0001673613,0.0002414875,0.0002165364,0.0001373216,0.0009009659,0.0002173106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002752757,"about_ca_system_score_gemma":0.0002696626,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001774112,"about_ca_topic_score_gemma":0.0002262511,"domain_scores_codex":[0.9997069,0.0001263779,0.00003725761,0.00003078701,0.00006006561,0.00003852225],"domain_scores_gemma":[0.9987936,0.0004365463,0.000318561,0.0001136784,0.0001106141,0.0002269265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04563254,0.005843937,0.09504945,0.001219886,0.0006246321,0.01371822,0.0006590399,0.00381594,0.1237187,0.001253758,0.003163431,0.7053005],"study_design_scores_gemma":[0.007530345,0.2930274,0.4243809,0.0005897044,0.002193431,0.07455602,0.0005544556,0.0157088,0.1154815,0.002831077,0.06304985,0.00009650148],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977672,0.01449777,0.001847604,0.0007579096,0.0001078893,0.00008913127,0.0001003202,0.00003650103,0.00489071],"genre_scores_gemma":[0.9982913,0.000856578,0.000251615,0.0001719317,0.0001127641,0.00001772802,0.00006446491,0.000004406713,0.0002291136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008877647,"threshold_uncertainty_score":0.004694998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2795166918","doi":"10.1186/s40425-017-0313-7","title":"Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment","year":2018,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":108,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Metropolitan University","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; National Science Foundation","keywords":"Tumor microenvironment; Tumor progression; Cancer research; Angiogenesis; Macrophage; Population; Cancer; Medicine; Monocyte; Immunology; Chemistry; Internal medicine; Tumor cells; In vitro","authors":[{"name":"Grace E. Mahlbacher","is_ca":false},{"name":"Louis T. Curtis","is_ca":false},{"name":"John Lowengrub","is_ca":true},{"name":"Hermann B. Frieboes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0158989538304639,"gpt":0.3001841164475346,"spread":0.2842851626170707,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005541906,0.000985265,0.0007948641,0.0007564718,0.0005763689,0.001375953,0.001227644,0.002529709,0.002411096],"category_scores_gemma":[0.001821106,0.0005627708,0.001252218,0.0006134909,0.0008543379,0.0008412529,0.00121778,0.0009287915,0.000459868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001201278,"about_ca_system_score_gemma":0.001265841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0134448,"about_ca_topic_score_gemma":0.005190592,"domain_scores_codex":[0.9997073,0.0001157799,0.00001159152,0.00004152288,0.00005833142,0.00006559848],"domain_scores_gemma":[0.9991365,0.000468653,0.000160066,0.0000295214,0.0001388891,0.00006636275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.00001622552,0.00002052086,0.000784102,0.00003748462,0.00001735095,0.000104396,0.00003163962,0.9836377,0.001214346,0.01270693,0.0004260066,0.001003352],"study_design_scores_gemma":[0.000004301702,0.000005779714,0.00009835165,0.000004550571,0.000003851199,0.00001613048,0.000008011942,0.9977394,0.00007586651,0.001661786,0.0003782707,0.00000366979],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.2213922,0.004408223,0.7057743,0.00487822,0.0003503816,0.0002080944,0.001495977,0.000424711,0.06106792],"genre_scores_gemma":[0.9325097,0.002506212,0.03701955,0.0004639323,0.0001757766,0.0005294404,0.0005620663,0.0001466695,0.02608671],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0134448,"threshold_uncertainty_score":0.0267331,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3173127935","doi":"10.1136/jitc-2020-002157","title":"Follicular helper-T cells restore CD8<sup>+</sup>-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Ligue Contre le Cancer; Agence Nationale de la Recherche; Université de Franche-Comté; Fondation de France; Université Laval; Université de Bourgogne; Association pour la Recherche sur le Cancer","keywords":"Germinal center; Cytotoxic T cell; Immune system; CD8; Chemokine; Immunology; Cancer research; Biology; T cell; Adoptive cell transfer; Antibody; Flow cytometry; Cytokine; B cell; In vitro","authors":[{"name":"Julie Niogret","is_ca":false},{"name":"Hélène Berger","is_ca":false},{"name":"Cédric Rébé","is_ca":false},{"name":"Romain Mary","is_ca":false},{"name":"Elise Ballot","is_ca":false},{"name":"Caroline Truntzer","is_ca":false},{"name":"Marion Thibaudin","is_ca":false},{"name":"Valentin Dérangère","is_ca":false},{"name":"Christophe Hibos","is_ca":false},{"name":"Léa Hampe","is_ca":false},{"name":"David Rageot","is_ca":false},{"name":"Théo Accogli","is_ca":true},{"name":"Philippe Joubert","is_ca":true},{"name":"Bertrand Routy","is_ca":true},{"name":"James A. Harker","is_ca":false},{"name":"Frédérique Végran","is_ca":false},{"name":"François Ghiringhelli","is_ca":false},{"name":"Fanny Chalmin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02059658743093797,"gpt":0.3176562006179244,"spread":0.2970596131869864,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000141199,0.0003280443,0.0002792777,0.0002818013,0.0001152227,0.0003194188,0.0002122866,0.000272275,0.002875905],"category_scores_gemma":[0.0001420888,0.0000787973,0.000248692,0.0001089952,0.0001980797,0.0001734004,0.0001844716,0.0009245762,0.0009607124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002078074,"about_ca_system_score_gemma":0.0002471539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001961744,"about_ca_topic_score_gemma":0.0002539423,"domain_scores_codex":[0.9998386,0.00001556503,0.00001337551,0.00003372114,0.00003405993,0.00006466372],"domain_scores_gemma":[0.999836,0.00002203412,0.00004217733,0.0000202075,0.00002278423,0.00005684036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007498066,0.0003039511,0.000556763,0.0001273666,0.00001311261,0.00009653565,0.00002752313,0.000159222,0.9806262,0.0002126653,0.0006410317,0.01648581],"study_design_scores_gemma":[0.0002575688,0.003170287,0.004893912,0.00002431823,0.00005754733,0.0007625833,0.00006356679,0.00136184,0.9677337,0.0003623663,0.02130304,0.000009227042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869419,0.002696592,0.004468854,0.0002360743,0.0001448789,0.0001143869,0.00107097,0.0006786998,0.003647877],"genre_scores_gemma":[0.9892653,0.0005668508,0.003308793,0.0001859965,0.00007900796,0.0001017993,0.001208022,0.00008907501,0.005195128],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002875905,"threshold_uncertainty_score":0.009620845,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4297387081","doi":"10.1136/jitc-2022-005187","title":"GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Occupational Cancer Research Centre","funders":"Mark Hughes Foundation; Medical Research Council; Flinders Foundation; Tour de Cure; Australian Cancer Research Foundation; Fay Fuller Foundation; Cancer Australia; Cancer Council South Australia; Neurosurgical Research Foundation; National Health and Medical Research Council; Hospital Research Foundation","keywords":"Chimeric antigen receptor; Medicine; Glioma; Flow cytometry; Cancer research; Brain tumor; Antigen; Immune system; Immunotherapy; Tumor antigen; Pathology; Oncology; Immunology","authors":[{"name":"Tessa Gargett","is_ca":false},{"name":"Lisa M. Ebert","is_ca":false},{"name":"Nga Truong","is_ca":false},{"name":"Paris M. Kollis","is_ca":false},{"name":"Kristýna Šediváková","is_ca":false},{"name":"Wenbo Yu","is_ca":false},{"name":"Erica C. F. Yeo","is_ca":false},{"name":"Nicole L. Wittwer","is_ca":false},{"name":"Briony L. Gliddon","is_ca":false},{"name":"Melinda N. Tea","is_ca":false},{"name":"Rebecca J. Ormsby","is_ca":false},{"name":"Santosh Poonnoose","is_ca":false},{"name":"Jake Nowicki","is_ca":false},{"name":"Orazio Vittorio","is_ca":true},{"name":"David S. Ziegler","is_ca":true},{"name":"Stuart M. Pitson","is_ca":false},{"name":"Michael P. Brown","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02121667910910916,"gpt":0.3714376681463423,"spread":0.3502209890372331,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001543451,0.00028197,0.000193403,0.0003156391,0.00008488945,0.0002685115,0.0001645593,0.0001977429,0.0008463617],"category_scores_gemma":[0.00009214885,0.00008709044,0.0002123815,0.0002073136,0.0002157605,0.0001229429,0.0001412925,0.0003095846,0.0002342805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002589542,"about_ca_system_score_gemma":0.000355413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005362291,"about_ca_topic_score_gemma":0.001103566,"domain_scores_codex":[0.9999107,0.000009883474,0.000008228597,0.00001768047,0.00003309673,0.00002039945],"domain_scores_gemma":[0.999966,0.000003978339,0.00001024845,0.000005018617,0.000006601972,0.000008116754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001769926,0.00005275425,0.0008241292,0.00006267585,0.00001279683,0.00007016069,0.00001914218,0.0002319189,0.9885257,0.0001280564,0.0002608644,0.009634698],"study_design_scores_gemma":[0.00005865044,0.0008884222,0.005759154,0.00001266628,0.00006598373,0.0004432277,0.00002072622,0.0009190247,0.9840178,0.0001200833,0.007688397,0.000005818017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979837,0.00498104,0.01135648,0.0002838311,0.00004938101,0.0001648613,0.000636415,0.0003940838,0.002296904],"genre_scores_gemma":[0.986278,0.002203776,0.008277621,0.0001675767,0.0000141872,0.00008337925,0.001103985,0.0000387876,0.001832643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008463617,"threshold_uncertainty_score":0.00283134,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4280541127","doi":"10.1136/jitc-2021-004076","title":"Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Cilag; Foundation Medicine; Takeda Oncology; Chugai Pharmaceutical; Novartis Pharma; Genentech; Daiichi Sankyo Europe; National Cancer Institute; Servier; Eisai; Basilea Pharmaceutica; AstraZeneca; Institut National Du Cancer; Seagen; Agios Pharmaceuticals; Eisai Canada; BeiGene; Clovis Oncology; Loxo Oncology; Astex Pharmaceuticals; Les Laboratories Pierre Fabre; Boston Pharmaceuticals; Taiho Pharmaceutical; F. Hoffmann-La Roche; Yale University; Bayer HealthCare; Exelixis; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Celgene; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Atezolizumab; Blockade; Solid tumor; Medicine; Immune checkpoint; Immune system; Oncology; Cancer research; Internal medicine; Immunology; Immunotherapy; Pembrolizumab; Cancer; Receptor","authors":[{"name":"Carlos Gomez‐Roca","is_ca":false},{"name":"Philippe A. Cassier","is_ca":false},{"name":"Dmitriy Zamarin","is_ca":false},{"name":"Jean‐Pascal Machiels","is_ca":false},{"name":"José Luis Perez‐Gracia","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Álvaro Taus","is_ca":false},{"name":"Maria Martinez‐García","is_ca":false},{"name":"Valentina Boni","is_ca":false},{"name":"Joseph P. Eder","is_ca":false},{"name":"Navid Hafez","is_ca":false},{"name":"Ryan J. Sullivan","is_ca":false},{"name":"David F. McDermott","is_ca":false},{"name":"Stéphane Champiat","is_ca":false},{"name":"Sandrine Aspeslagh","is_ca":false},{"name":"C. Terret","is_ca":false},{"name":"Anna-Maria Jegg","is_ca":false},{"name":"Wolfgang Jacob","is_ca":false},{"name":"Michael A. Cannarile","is_ca":false},{"name":"Carola H. Ries","is_ca":false},{"name":"Konstanty Korski","is_ca":false},{"name":"Francesca Michielin","is_ca":false},{"name":"R D Christen","is_ca":false},{"name":"Galina Babitzki","is_ca":false},{"name":"Carl Watson","is_ca":false},{"name":"Georgina Meneses‐Lorente","is_ca":false},{"name":"Maja Weisser","is_ca":false},{"name":"Dominik Rüttinger","is_ca":false},{"name":"Jean‐Pierre Delord","is_ca":false},{"name":"Aurélien Marabelle","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01447742620359424,"gpt":0.325284274372232,"spread":0.3108068481686377,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001053192,0.0005466001,0.001216006,0.000279093,0.000182351,0.0005151841,0.000388647,0.00041024,0.0009277809],"category_scores_gemma":[0.0006988535,0.0002476549,0.0006913616,0.000264852,0.0003523924,0.0003153386,0.0002092259,0.001314263,0.000274104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005504628,"about_ca_system_score_gemma":0.0007170311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004078829,"about_ca_topic_score_gemma":0.001033747,"domain_scores_codex":[0.9997055,0.0001395882,0.00002207625,0.00004830558,0.00003582205,0.00004872592],"domain_scores_gemma":[0.999619,0.00009019605,0.0001023092,0.00002604664,0.00002018484,0.0001422233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4262984,0.04570897,0.06242708,0.001217989,0.001869522,0.0008847377,0.0005779015,0.007895559,0.124288,0.0002828668,0.00357472,0.3249742],"study_design_scores_gemma":[0.1748037,0.7227908,0.07572568,0.00008204082,0.0007144657,0.001415394,0.00006882265,0.005479323,0.01357643,0.0001530694,0.005153318,0.00003689077],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980617,0.001009102,0.0001550761,0.00008280504,0.00002070231,0.0001581171,0.00009553006,0.00001679286,0.000400201],"genre_scores_gemma":[0.9982458,0.000503264,0.0004058419,0.0001146241,0.00003503383,0.0001361,0.0002571836,0.00000517737,0.0002969419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001216006,"threshold_uncertainty_score":0.005569935,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3201513519","doi":"10.1136/jitc-2021-002954","title":"Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Japan Society for the Promotion of Science; Ono Pharmaceutical; Secom Science and Technology Foundation","keywords":"mTORC1; Mitochondrial ROS; Cancer research; Glutaminolysis; Reactive oxygen species; Mitochondrion; Metformin; Chemistry; Biology; Cell biology; Cancer cell; Cancer; Signal transduction; PI3K/AKT/mTOR pathway; Endocrinology","authors":[{"name":"Mikako Nishida","is_ca":false},{"name":"Nahoko Yamashita","is_ca":false},{"name":"Taisaku Ogawa","is_ca":false},{"name":"Keita Koseki","is_ca":false},{"name":"Eiji Warabi","is_ca":false},{"name":"Tomoyuki Ohue","is_ca":false},{"name":"Masaaki Komatsu","is_ca":false},{"name":"Hirokazu Matsushita","is_ca":false},{"name":"Kazuhiro Kakimi","is_ca":false},{"name":"Eiryo Kawakami","is_ca":true},{"name":"Katsuyuki Shiroguchi","is_ca":false},{"name":"Heiichiro Udono","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01487345650998473,"gpt":0.2909870561444415,"spread":0.2761135996344568,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000835812,0.0002145579,0.0001598587,0.0001667893,0.00009854804,0.0001601204,0.00008646163,0.0001973942,0.001849107],"category_scores_gemma":[0.00006413029,0.00006181072,0.0001531608,0.00008826276,0.0001207189,0.0001570246,0.0001168022,0.0003669382,0.0002973067],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000103992,"about_ca_system_score_gemma":0.00008217015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006941704,"about_ca_topic_score_gemma":0.0001524646,"domain_scores_codex":[0.9999068,0.00001262058,0.000009991149,0.00002474369,0.00001742974,0.00002847278],"domain_scores_gemma":[0.9999447,0.000005208878,0.00002245981,0.00000440977,0.000007324689,0.00001596981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003794521,0.00005121165,0.0005854173,0.00006091558,0.000003725227,0.0000543611,0.00001546365,0.00003496026,0.9971856,0.00005781959,0.00005830632,0.001512785],"study_design_scores_gemma":[0.0000869817,0.0009235317,0.01227872,0.00001429659,0.00002911156,0.0003859386,0.00008705697,0.0009190949,0.9822698,0.000175357,0.002825208,0.000004898358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958186,0.0009762553,0.001609413,0.0001077675,0.00002743946,0.00002770324,0.0003115797,0.00007079684,0.001050631],"genre_scores_gemma":[0.9965796,0.0004202113,0.001225413,0.0000656177,0.00001881812,0.00006011372,0.0002729796,0.00001266231,0.001344606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001849107,"threshold_uncertainty_score":0.006185889,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2298802783","doi":"10.1186/s40425-016-0116-2","title":"Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study","year":2016,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"University of California, San Diego; U.S. Food and Drug Administration; Amgen","keywords":"Medicine; Oncolytic virus; Melanoma; Internal medicine; Oncology; Cancer research; Cancer","authors":[{"name":"Howard L. Kaufman","is_ca":false},{"name":"Thomas Amatruda","is_ca":false},{"name":"Tony Reid","is_ca":false},{"name":"René González","is_ca":false},{"name":"John A. Glaspy","is_ca":false},{"name":"Eric D. Whitman","is_ca":false},{"name":"Kevin J. Harrington","is_ca":true},{"name":"John Nemunaitis","is_ca":false},{"name":"Andrew Zloza","is_ca":false},{"name":"Michael Wolf","is_ca":false},{"name":"Neil Senzer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02881937285232573,"gpt":0.3572661509682807,"spread":0.328446778115955,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001280991,0.0005174335,0.0009180646,0.0002334413,0.0002448831,0.0004243809,0.0002916238,0.0004144753,0.001449458],"category_scores_gemma":[0.0005201887,0.0002263034,0.0004591131,0.0002250497,0.000398047,0.0003264314,0.0002101003,0.00113885,0.0002143784],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003264081,"about_ca_system_score_gemma":0.0004213724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000219541,"about_ca_topic_score_gemma":0.0004533011,"domain_scores_codex":[0.999642,0.0001693447,0.00002137202,0.00006194321,0.00004269627,0.00006265581],"domain_scores_gemma":[0.9994018,0.0001377877,0.0001408986,0.00006947076,0.00003462031,0.000215347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3735938,0.07586423,0.09979652,0.000659052,0.001591815,0.0004852661,0.0004532941,0.003021291,0.3399124,0.0001429522,0.001760143,0.1027193],"study_design_scores_gemma":[0.04952855,0.7890071,0.1266216,0.00002514325,0.0006732255,0.0007076529,0.0001173735,0.001607188,0.02984587,0.00006129153,0.001779012,0.00002594153],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989875,0.000317187,0.0001315138,0.00002088196,0.000008406538,0.0001982913,0.0000956214,0.000009698851,0.0002309317],"genre_scores_gemma":[0.9983467,0.000208682,0.0002974765,0.00009531059,0.00004240565,0.0002859101,0.0004167153,0.00000464371,0.0003021731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001449458,"threshold_uncertainty_score":0.006774604,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3036508677","doi":"10.1136/jitc-2020-000840","title":"Chronic immune checkpoint inhibitor pneumonitis","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Pneumonitis; Immunosuppression; Hypersensitivity pneumonitis; Internal medicine; Bronchoalveolar lavage; Immunology; Gastroenterology; Lung","authors":[{"name":"Jarushka Naidoo","is_ca":false},{"name":"Tricia R. Cottrell","is_ca":true},{"name":"Evan J. Lipson","is_ca":false},{"name":"Patrick M. Forde","is_ca":false},{"name":"Peter B. Illei","is_ca":false},{"name":"Lonny Yarmus","is_ca":false},{"name":"Khinh Ranh Voong","is_ca":false},{"name":"David Feller‐Kopman","is_ca":false},{"name":"Hans C. Lee","is_ca":false},{"name":"Joanne Riemer","is_ca":false},{"name":"Daphne Wang","is_ca":false},{"name":"Janis M. Taube","is_ca":false},{"name":"Julie R. Brahmer","is_ca":false},{"name":"Cheng Ting Lin","is_ca":false},{"name":"Sonye K. Danoff","is_ca":false},{"name":"Franco R. D’Alessio","is_ca":false},{"name":"Karthik Suresh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02450206369274763,"gpt":0.3195411143344083,"spread":0.2950390506416607,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004092104,0.0001774696,0.0003452185,0.0003659516,0.0002958947,0.0004942677,0.0002084003,0.0002180638,0.003281461],"category_scores_gemma":[0.0007927812,0.00008433409,0.0002655245,0.0004953688,0.0001929589,0.0002837375,0.0003000406,0.0002949343,0.0003909321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003128233,"about_ca_system_score_gemma":0.0003708277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007763192,"about_ca_topic_score_gemma":0.001231318,"domain_scores_codex":[0.9995335,0.0000618784,0.00009908474,0.00009691653,0.0001071045,0.0001014542],"domain_scores_gemma":[0.9984664,0.0001521264,0.001032043,0.00005411416,0.0001194673,0.0001758104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.0002228325,0.00005456528,0.9824516,0.0001364524,0.00006967182,0.001721745,0.00003517453,0.00005518074,0.001292394,0.0000806261,0.0006972962,0.01318238],"study_design_scores_gemma":[0.00006631569,0.0005476741,0.9553543,0.0001407912,0.0001044894,0.03439927,0.0001159739,0.0004979202,0.001307475,0.0001060213,0.007352754,0.000007042764],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979636,0.0102674,0.0007111939,0.0002562575,0.00002847044,0.0001109808,0.001157172,0.00003995564,0.007792631],"genre_scores_gemma":[0.997349,0.0009497335,0.0002174609,0.0001207217,0.00005867687,0.00002168232,0.0007651436,0.000002757056,0.0005146876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003281461,"threshold_uncertainty_score":0.01097763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2921822469","doi":"10.1186/s40425-019-0521-4","title":"The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pancreas Centre (Canada)","funders":"Associazione Italiana per la Ricerca sul Cancro; Worldwide Cancer Research","keywords":"Inflammasome; Signal transducing adaptor protein; Pancreatic cancer; Secretion; Cancer research; Cancer; Receptor; Medicine; Chemistry; Internal medicine","authors":[{"name":"Emanuela Brunetto","is_ca":false},{"name":"Lucia De Monte","is_ca":false},{"name":"Gianpaolo Balzano","is_ca":true},{"name":"Barbara Camisa","is_ca":false},{"name":"Vincenzo Laino","is_ca":false},{"name":"Michela Riba","is_ca":false},{"name":"Silvia Heltai","is_ca":false},{"name":"Marco E. Bianchi","is_ca":false},{"name":"Claudio Bordignon","is_ca":false},{"name":"Massimo Falconi","is_ca":true},{"name":"Attilio Bondanza","is_ca":false},{"name":"Claudio Doglioni","is_ca":false},{"name":"Maria Pia Protti","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.003735799338267266,"gpt":0.2335305472925836,"spread":0.2297947479543164,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004198342,0.0005527911,0.0004758416,0.0008231637,0.0002421486,0.0008207142,0.000178753,0.0003157206,0.002029404],"category_scores_gemma":[0.0004040976,0.0001621902,0.0005335293,0.0006977242,0.0002200805,0.0004128129,0.000290315,0.0005231043,0.0007340834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003010604,"about_ca_system_score_gemma":0.0003152833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001494908,"about_ca_topic_score_gemma":0.0002152376,"domain_scores_codex":[0.9995413,0.00005968874,0.0000707509,0.0001076558,0.0001465838,0.0000740909],"domain_scores_gemma":[0.9994056,0.00007051761,0.0003294573,0.0000338661,0.0000677869,0.00009281289],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001060396,0.00007334107,0.01289637,0.0006404848,0.00005642841,0.0007381816,0.00008591047,0.0002941633,0.9722158,0.0001441845,0.0004376909,0.01135699],"study_design_scores_gemma":[0.0001996007,0.001129569,0.259243,0.0001569479,0.0004389406,0.006869304,0.0005295866,0.005976787,0.7007436,0.001036238,0.02361442,0.00006211292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9626931,0.02128011,0.006736189,0.0004350526,0.00009855282,0.0001155214,0.006497174,0.0004071168,0.001737309],"genre_scores_gemma":[0.9807623,0.006505813,0.006453869,0.0001207459,0.00008271977,0.0001150197,0.004940842,0.00004205143,0.0009766548],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002029404,"threshold_uncertainty_score":0.006788969,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2157899115","doi":"10.1186/s40425-014-0041-1","title":"Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma","year":2014,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Retinal vasculitis; Extravasation; Pembrolizumab; Melanoma; Vasculitis; Metastasis; Retinal; Nivolumab; Optic nerve; Vitreous hemorrhage; Immune system; Immunotherapy; Pathology; Ophthalmology; Cancer research; Immunology; Retinal detachment; Internal medicine; Cancer; Disease","authors":[{"name":"Joshua S. Manusow","is_ca":true},{"name":"Leila Khoja","is_ca":true},{"name":"Nataly Pesin","is_ca":true},{"name":"Anthony M. Joshua","is_ca":true},{"name":"Efrem D. Mandelcorn","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01311145904582377,"gpt":0.301956724692727,"spread":0.2888452656469032,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003411644,0.0006978465,0.0006845829,0.0009407852,0.001306917,0.0008235878,0.0005045877,0.002096966,0.001341101],"category_scores_gemma":[0.001838021,0.0005135936,0.0007215766,0.0005262508,0.0006923761,0.0006578458,0.0004530199,0.001821915,0.0003717735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007087424,"about_ca_system_score_gemma":0.0004118797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001937169,"about_ca_topic_score_gemma":0.00256912,"domain_scores_codex":[0.9997117,0.00004650083,0.00002666809,0.00007158461,0.000041968,0.0001015852],"domain_scores_gemma":[0.9992597,0.0002196048,0.0001590616,0.00005890983,0.00004277439,0.0002600146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.0001959825,0.00007330918,0.02362684,0.00003827587,0.00002173114,0.9711316,0.0002296999,0.0001256038,0.001904796,0.0001375608,0.0001939846,0.002320572],"study_design_scores_gemma":[0.00003566155,0.0005493844,0.02389814,0.00001613228,0.00004939052,0.9730456,0.0001367597,0.0004663052,0.001041585,0.0001258033,0.0006195231,0.00001565608],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876896,0.002749339,0.001163717,0.001637022,0.0001171304,0.0001007051,0.0001417962,0.0001028081,0.006297829],"genre_scores_gemma":[0.9982572,0.0005104371,0.0003080328,0.0002733961,0.00011549,0.000005699514,0.00003563474,0.00000717292,0.0004869219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002096966,"threshold_uncertainty_score":0.005142331,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2906255446","doi":"10.1186/s40425-018-0457-0","title":"PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity","year":2018,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":89,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"PI3K/AKT/mTOR pathway; Tumor microenvironment; Immune system; CD8; Cancer research; T cell; Effector; Cytotoxic T cell; Immunosuppression; Immunotherapy; Biology; Chemistry; Pharmacology; Immunology; Medicine; Cell biology; In vitro; Signal transduction; Biochemistry","authors":[{"name":"Larissa S. Carnevalli","is_ca":true},{"name":"Charles Sinclair","is_ca":true},{"name":"Molly A. Taylor","is_ca":true},{"name":"Pablo Morentin Gutierrez","is_ca":true},{"name":"Sophie Langdon","is_ca":true},{"name":"Anna Coenen-Stass","is_ca":true},{"name":"Lorraine Mooney","is_ca":true},{"name":"Adina Hughes","is_ca":true},{"name":"Laura Jarvis","is_ca":true},{"name":"Anna D. Staniszewska","is_ca":true},{"name":"Claire Crafter","is_ca":true},{"name":"Ben S. Sidders","is_ca":true},{"name":"Elizabeth Hardaker","is_ca":true},{"name":"Kevin Hudson","is_ca":true},{"name":"Simon T. Barry","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01591630376453932,"gpt":0.30009173386688,"spread":0.2841754301023406,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001156585,0.0004128455,0.0002367702,0.0001818186,0.00006699296,0.0002316023,0.000210223,0.0001479091,0.001113801],"category_scores_gemma":[0.00006223794,0.00009335436,0.0001488955,0.0001110036,0.0001496973,0.000168167,0.0001286784,0.0009803515,0.0002907693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001652377,"about_ca_system_score_gemma":0.0002077692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002272639,"about_ca_topic_score_gemma":0.0004995072,"domain_scores_codex":[0.9998972,0.00001302575,0.00001124411,0.00002323725,0.00002698969,0.00002832526],"domain_scores_gemma":[0.999963,0.000005678379,0.00001181409,0.000005044832,0.000003553452,0.00001082137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004470925,0.0001381481,0.0001544632,0.00006810202,0.00000945689,0.00001961274,0.000006933684,0.0001729857,0.9925991,0.00007485002,0.00009006423,0.006219211],"study_design_scores_gemma":[0.00008934114,0.001978256,0.00200046,0.00000567078,0.00002580397,0.0001495508,0.000009028429,0.001096901,0.992698,0.00004321714,0.001901337,0.000002434942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991761,0.002149687,0.003445513,0.000117528,0.00004531501,0.00007080552,0.0003863416,0.0001755531,0.001848236],"genre_scores_gemma":[0.994943,0.001034395,0.00215745,0.00004558935,0.00001271388,0.00005494181,0.0002492894,0.00001103959,0.001491637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001113801,"threshold_uncertainty_score":0.003726065,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2914393875","doi":"10.1186/s40425-018-0485-9","title":"Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":89,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; Swim Across America; National Institute of General Medical Sciences; KWF Kankerbestrijding; National Cancer Institute; National Institutes of Health; Cancer Prevention and Research Institute of Texas; National Institute of Allergy and Infectious Diseases; Deutsche Krebshilfe; Irving Medical Center, Columbia University; Owens Foundation; University of Texas MD Anderson Cancer Center","keywords":"Tumor microenvironment; Immune system; Head and neck squamous-cell carcinoma; Cancer research; Medicine; CD8; T cell; Mass cytometry; Myeloid; Antigen; Immunology; Cancer; Head and neck cancer; Biology; Internal medicine","authors":[{"name":"Aurélie Hanoteau","is_ca":false},{"name":"Jared M. Newton","is_ca":false},{"name":"Rosemarie Krupar","is_ca":false},{"name":"Chen Huang","is_ca":false},{"name":"Hsuan‐Chen Liu","is_ca":false},{"name":"Angelina Gaspero","is_ca":false},{"name":"Robyn D. Gartrell","is_ca":true},{"name":"Yvonne M. Saenger","is_ca":false},{"name":"Thomas D. Hart","is_ca":false},{"name":"Saskia J. Santegoets","is_ca":false},{"name":"Damya Laoui","is_ca":false},{"name":"Chad Spanos","is_ca":false},{"name":"Falguni Parikh","is_ca":false},{"name":"Padmini Jayaraman","is_ca":false},{"name":"Bing Zhang","is_ca":false},{"name":"Sjoerd H. van der Burg","is_ca":false},{"name":"Jo A. Van Ginderachter","is_ca":false},{"name":"Cornelis J.M. Melief","is_ca":false},{"name":"Andrew G. Sikora","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008691542132802798,"gpt":0.2691522417700022,"spread":0.2604606996371994,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009678425,0.0002068202,0.0002559269,0.0001432376,0.00008244219,0.0001935296,0.00009665485,0.000155572,0.001390383],"category_scores_gemma":[0.00008522069,0.00005133244,0.0001521193,0.00006414571,0.0001691069,0.00012009,0.0001233401,0.0003726608,0.0001912248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001511866,"about_ca_system_score_gemma":0.0001365144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008819302,"about_ca_topic_score_gemma":0.0001614212,"domain_scores_codex":[0.9999018,0.00002332061,0.000006635948,0.00001939237,0.00002215257,0.00002670357],"domain_scores_gemma":[0.9999256,0.00001600639,0.00002241425,0.000008399936,0.000008233445,0.00001937893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002184505,0.00009371294,0.0002988536,0.00004428688,0.000004830837,0.00002126803,0.000006579236,0.0001220625,0.9966878,0.00003221754,0.00002759647,0.002442218],"study_design_scores_gemma":[0.00004365375,0.002569737,0.007910986,0.00001064244,0.00003913437,0.0002669739,0.00001504913,0.0006821905,0.9860625,0.00002989209,0.002366105,0.000003184138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956313,0.002023642,0.0009571672,0.0000530659,0.0000216108,0.00004261282,0.00007611306,0.00006165522,0.001132768],"genre_scores_gemma":[0.998466,0.0004759736,0.0005144278,0.00002346959,0.00001452782,0.00002158772,0.00005749751,0.000006003303,0.0004204761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001390383,"threshold_uncertainty_score":0.004651368,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2947794723","doi":"10.1186/s40425-019-0602-4","title":"Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop","year":2019,"lang":"en","type":"review","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; Caprion (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto; University Health Network","funders":"National Center for Advancing Translational Sciences; Society for Immunotherapy of Cancer; National Cancer Institute; Celgene","keywords":"Premise; Cancer; Cancer immunotherapy; Immune escape; Immune system; Immunotherapy; Computational biology; Bioinformatics; Medicine; Immunology; Psychology; Biology; Genetics","authors":[{"name":"Davide Bedognetti","is_ca":false},{"name":"Michele Ceccarelli","is_ca":false},{"name":"Lorenzo Galluzzi","is_ca":false},{"name":"Rongze Lu","is_ca":false},{"name":"Karolina Palucka","is_ca":false},{"name":"Josue Samayoa","is_ca":false},{"name":"Stefani Spranger","is_ca":false},{"name":"Sarah Warren","is_ca":false},{"name":"Kwok‐Kin Wong","is_ca":false},{"name":"Elad Ziv","is_ca":false},{"name":"Diego Chowell","is_ca":false},{"name":"Lisa M. Coussens","is_ca":true},{"name":"Daniel D. De Carvalho","is_ca":true},{"name":"David G. DeNardo","is_ca":false},{"name":"Jérôme Galon","is_ca":false},{"name":"Howard L. Kaufman","is_ca":false},{"name":"Tomas Kirchhoff","is_ca":false},{"name":"Michael T. Lotze","is_ca":false},{"name":"Jason J. Luke","is_ca":false},{"name":"Andy J. Minn","is_ca":false},{"name":"Katerina Politi","is_ca":false},{"name":"Leonard D. Shultz","is_ca":false},{"name":"Richard Simon","is_ca":false},{"name":"Vésteinn Thórsson","is_ca":false},{"name":"Joanne B. Weidhaas","is_ca":false},{"name":"Maria Libera Ascierto","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"J. Matthew Barnes","is_ca":false},{"name":"Valentin Barsan","is_ca":false},{"name":"Praveen K. Bommareddy","is_ca":false},{"name":"Adrian Bot","is_ca":false},{"name":"S. Church","is_ca":false},{"name":"Gennaro Ciliberto","is_ca":false},{"name":"Andrea De Maria","is_ca":false},{"name":"Dobrin Draganov","is_ca":false},{"name":"Winson S. Ho","is_ca":false},{"name":"Heather M. McGee","is_ca":true},{"name":"Anne Monette","is_ca":true},{"name":"Joseph F. Murphy","is_ca":true},{"name":"Paola Nisticò","is_ca":false},{"name":"Wungki Park","is_ca":false},{"name":"Maulik Patel","is_ca":false},{"name":"Michael Quigley","is_ca":true},{"name":"Laszlo Radvanyi","is_ca":true},{"name":"Harry Raftopoulos","is_ca":false},{"name":"Nils-Petter Rudqvist","is_ca":false},{"name":"Alexandra Snyder","is_ca":false},{"name":"Randy F. Sweis","is_ca":false},{"name":"Sara Valpione","is_ca":false},{"name":"Roberta Zappasodi","is_ca":false},{"name":"Lisa H. Butterfield","is_ca":false},{"name":"Mary L. Disis","is_ca":false},{"name":"Bernard A. Fox","is_ca":false},{"name":"Alessandra Cesano","is_ca":false},{"name":"Francesco M. Marincola","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1124544231922615,"gpt":0.4196030258259771,"spread":0.3071486026337156,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01014652,0.002395454,0.001961659,0.00396329,0.002830341,0.008150669,0.00345311,0.009085089,0.005288097],"category_scores_gemma":[0.008615364,0.00105731,0.002338247,0.003469325,0.004061347,0.007973913,0.007830068,0.028084,0.003433864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008663019,"about_ca_system_score_gemma":0.009938831,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005675931,"about_ca_topic_score_gemma":0.007004432,"domain_scores_codex":[0.9963533,0.001076041,0.0004361269,0.0005067581,0.001183864,0.0004439363],"domain_scores_gemma":[0.9935801,0.002110644,0.0002230565,0.0001789142,0.00211638,0.001790996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006813205,0.00005773008,0.0001421056,0.001399926,0.00002291955,0.0002478678,0.0006348593,0.0004248604,0.0004958942,0.01176185,0.9498606,0.03488324],"study_design_scores_gemma":[0.000009962909,0.00003125441,0.0001889354,0.001821009,0.000009340222,0.0002042383,0.0002755073,0.00006660007,0.00006670941,0.003470203,0.9938356,0.00002065641],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005705694,0.4337459,0.002411402,0.3240432,0.2295256,0.0001615627,0.000315971,0.0000826057,0.009143153],"genre_scores_gemma":[0.007267773,0.5241578,0.003684222,0.257219,0.184371,0.0005557917,0.0008343969,0.0002300887,0.02167991],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01014652,"threshold_uncertainty_score":0.06285489,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3011361209","doi":"10.1136/jitc-2020-000530","title":"A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Nausea; Adverse effect; Internal medicine; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Gastroenterology; Tolerability; Antibody; Lung cancer; Oncology; Population; Monoclonal antibody; Toxicity; Phases of clinical research; Immunology","authors":[{"name":"Aung Naing","is_ca":false},{"name":"Justin F. Gainor","is_ca":false},{"name":"Hans Gelderblom","is_ca":false},{"name":"Patrick M. Forde","is_ca":false},{"name":"Marcus O. Butler","is_ca":true},{"name":"Chia‐Chi Lin","is_ca":false},{"name":"Sunil Sharma","is_ca":false},{"name":"María Ochoa de Olza","is_ca":false},{"name":"Andréa Varga","is_ca":false},{"name":"Matthew H. Taylor","is_ca":false},{"name":"Jan H.M. Schellens","is_ca":false},{"name":"Hongqian Wu","is_ca":false},{"name":"Haiying Sun","is_ca":false},{"name":"Antonio P. Silva","is_ca":false},{"name":"Jason E. Faris","is_ca":false},{"name":"Jennifer Mataraza","is_ca":false},{"name":"Scott B. Cameron","is_ca":false},{"name":"Todd M. Bauer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02102198637447333,"gpt":0.3722325480268819,"spread":0.3512105616524085,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001678028,0.001460201,0.001528732,0.0003923917,0.0004138779,0.0006902326,0.0006443501,0.0008763353,0.002556538],"category_scores_gemma":[0.0008856825,0.0005597515,0.001016963,0.0003143223,0.000774541,0.0006805249,0.0003307349,0.003491574,0.0006841032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008663404,"about_ca_system_score_gemma":0.001400266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006089758,"about_ca_topic_score_gemma":0.001071094,"domain_scores_codex":[0.9995787,0.000190298,0.00002034332,0.00007437969,0.00004773629,0.0000885515],"domain_scores_gemma":[0.9993261,0.0001247117,0.0001137725,0.00006836069,0.00005065893,0.0003164954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4540673,0.2262675,0.02059254,0.001054781,0.001424893,0.0006918402,0.0008945968,0.005735398,0.1120412,0.0003565274,0.007368842,0.1695045],"study_design_scores_gemma":[0.3789334,0.5914332,0.01809499,0.00002268703,0.0002659811,0.000471134,0.00004298908,0.001512108,0.005809317,0.0001959374,0.00318945,0.00002875756],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996062,0.0007394303,0.0005123816,0.0002580913,0.000049038,0.001178196,0.0004337815,0.0000572371,0.0007099414],"genre_scores_gemma":[0.9921217,0.0007037473,0.002058634,0.0006996525,0.0001170483,0.001356933,0.001590847,0.0000257238,0.001325646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002556538,"threshold_uncertainty_score":0.008874416,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2948878352","doi":"10.1186/s40425-019-0619-8","title":"DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization; Queen's University","keywords":"Immunoediting; Bladder cancer; Immune checkpoint; DNA repair; Immune system; Gene; Cancer; Cancer research; DNA mismatch repair; Immunotherapy; Tumor microenvironment; Medicine; Bioinformatics; Biology; Immunology; Genetics; Internal medicine","authors":[{"name":"Thiago Vidotto","is_ca":false},{"name":"Sarah Nersesian","is_ca":true},{"name":"Charles H. Graham","is_ca":true},{"name":"D. Robert Siemens","is_ca":true},{"name":"Madhuri Koti","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01039549257959938,"gpt":0.275885229973412,"spread":0.2654897373938127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001813733,0.0001012822,0.0001816426,0.0008022644,0.00014766,0.0003065317,0.0001194405,0.0001762082,0.0008832049],"category_scores_gemma":[0.0004325129,0.00007253332,0.0001577891,0.0006477871,0.0001215778,0.00009520596,0.0001623477,0.0001960824,0.0001248487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001692422,"about_ca_system_score_gemma":0.0001083566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008560051,"about_ca_topic_score_gemma":0.001955847,"domain_scores_codex":[0.999872,0.00001567234,0.00001236609,0.00004624848,0.00002806327,0.00002567878],"domain_scores_gemma":[0.9997001,0.00006556867,0.0001492412,0.00001969416,0.00003373963,0.00003175363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006745294,0.00003407739,0.9334603,0.0001125738,0.000100295,0.0001233085,0.000152101,0.0002359627,0.05450229,0.00004846109,0.0002161836,0.01033987],"study_design_scores_gemma":[0.000003007904,0.00006397384,0.994003,0.000008060922,0.00004112135,0.0004106709,0.0001067457,0.0003508842,0.004516181,0.00004096369,0.0004525707,0.000002910402],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983206,0.0004711288,0.000159328,0.00001534274,0.00000149189,0.000006622094,0.0008156151,0.000007038481,0.000202828],"genre_scores_gemma":[0.9981275,0.000194083,0.0003408824,0.00001803989,0.000002783016,0.0000179295,0.00106032,0.000003445719,0.0002351244],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008832049,"threshold_uncertainty_score":0.002954543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3112961014","doi":"10.1136/jitc-2020-001849","title":"Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Faculty of Medicine and Dentistry, University of Alberta; Canadian Institutes of Health Research; University of Alberta; Alberta Cancer Foundation","keywords":"TIGIT; Cytotoxic T cell; T cell; Downregulation and upregulation; IL-2 receptor; Cancer research; Interleukin 21; Immunology; Galectin; CD8; Biology; Medicine; Immune system; In vitro","authors":[{"name":"Isobel Okoye","is_ca":true},{"name":"Lai Xu","is_ca":true},{"name":"Melika Motamedi","is_ca":true},{"name":"Pallavi Parashar","is_ca":true},{"name":"John Walker","is_ca":true},{"name":"Shokrollah Elahi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0109078295511333,"gpt":0.2508194246248309,"spread":0.2399115950736976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002483527,0.0002342553,0.0003615906,0.0003011252,0.0001824651,0.0004577004,0.0001307391,0.000265205,0.001289253],"category_scores_gemma":[0.0004273566,0.0001520691,0.0002061279,0.0002416326,0.000247243,0.0002502583,0.0002394842,0.0003161417,0.0001629832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001710549,"about_ca_system_score_gemma":0.0001020351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001309336,"about_ca_topic_score_gemma":0.0001385262,"domain_scores_codex":[0.9998703,0.00003275052,0.00001574718,0.00004094686,0.00001561424,0.00002465975],"domain_scores_gemma":[0.9997589,0.00006111309,0.00008207055,0.00001719636,0.00001948683,0.00006109304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01020853,0.0003624462,0.8903636,0.0001245031,0.0001541634,0.001457943,0.000205407,0.0003735489,0.07630726,0.0001221471,0.0002337849,0.02008659],"study_design_scores_gemma":[0.0003811449,0.005670283,0.9751837,0.00002625211,0.0001853107,0.007966247,0.0002606493,0.001199386,0.007899214,0.0002326133,0.0009828456,0.00001242404],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994099,0.0002442009,0.00006637521,0.000008025586,0.000001753361,0.00000845241,0.0000416951,0.000003084396,0.0002164388],"genre_scores_gemma":[0.999765,0.00003846273,0.00005886496,0.000009574561,0.000002753836,0.000004192777,0.00007074049,0.000001028172,0.00004943972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001289253,"threshold_uncertainty_score":0.004312992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2916703154","doi":"10.1186/s40425-019-0507-2","title":"Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital; Toronto General Hospital; University of Toronto; University Health Network","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Lung cancer; Cancer; Cancer research; Ligand (biochemistry); Medicine; Computational biology; Bioinformatics; Chemistry; Biology; Immunology; Oncology; Receptor; Internal medicine","authors":[{"name":"Junlin Yao","is_ca":true},{"name":"Dalam Ly","is_ca":true},{"name":"Dzana Dervovic","is_ca":true},{"name":"Linan Fang","is_ca":true},{"name":"Jong Bok Lee","is_ca":true},{"name":"Hyeonjeong Kang","is_ca":true},{"name":"Yuhui Wang","is_ca":true},{"name":"Nhu‐An Pham","is_ca":true},{"name":"Hongming Pan","is_ca":false},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Li Zhang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01122254260838088,"gpt":0.2874408932894919,"spread":0.276218350681111,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001342435,0.0003320039,0.0002083476,0.000113988,0.00007813845,0.000301328,0.0001366113,0.000240686,0.001498437],"category_scores_gemma":[0.0001354109,0.00006151494,0.0001656529,0.00007503331,0.0001667429,0.0001786833,0.0001734155,0.000422776,0.0004213686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001613078,"about_ca_system_score_gemma":0.0001133967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007245526,"about_ca_topic_score_gemma":0.0001351219,"domain_scores_codex":[0.9998611,0.00002655712,0.00001613443,0.00003650097,0.00002879198,0.00003081438],"domain_scores_gemma":[0.9999105,0.0000145152,0.00002876931,0.00001367959,0.00000989176,0.00002267248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002425595,0.00006048134,0.0009744035,0.00007596659,0.000007977993,0.0001510115,0.00002086085,0.0001094039,0.9930408,0.0001530606,0.0001176965,0.005045725],"study_design_scores_gemma":[0.0001469619,0.002491655,0.006717511,0.00003628196,0.00008787209,0.004316618,0.00005914455,0.001994362,0.9703681,0.0002133178,0.01355798,0.00001029523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989467,0.00378566,0.004079039,0.0001108422,0.00004851216,0.00007380253,0.000219265,0.00008028994,0.002135565],"genre_scores_gemma":[0.996021,0.0007738114,0.001566927,0.00007391012,0.00001927904,0.00004120247,0.0002424828,0.000007901578,0.001253656],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001498437,"threshold_uncertainty_score":0.005012751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2529221862","doi":"10.1186/s40425-016-0171-8","title":"Antitumor activity of nivolumab on hemodialysis after renal allograft rejection","year":2016,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Nivolumab; Hemodialysis; Ipilimumab; Transplantation; Immunosuppression; Internal medicine; Malignancy; Cancer; Intensive care medicine; Oncology; Immunotherapy","authors":[{"name":"Michael Ong","is_ca":true},{"name":"Andrea Marie Ibrahim","is_ca":true},{"name":"Samuel Bourassa‐Blanchette","is_ca":true},{"name":"Christina Canil","is_ca":true},{"name":"Todd Fairhead","is_ca":true},{"name":"Greg Knoll","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0154003820943477,"gpt":0.3142398967511063,"spread":0.2988395146567586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002313191,0.0001478245,0.0003103364,0.0001885156,0.000433806,0.0003011071,0.0002273904,0.0005153362,0.0004121238],"category_scores_gemma":[0.0008063333,0.00005109606,0.0003105448,0.0001014423,0.0001705085,0.0002012692,0.0001546809,0.0007460794,0.00009450388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004681573,"about_ca_system_score_gemma":0.0003281313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005304607,"about_ca_topic_score_gemma":0.0009060299,"domain_scores_codex":[0.9998788,0.00003430403,0.00001206843,0.0000182771,0.00002454026,0.0000320171],"domain_scores_gemma":[0.999707,0.0001003401,0.00005455305,0.00002646384,0.00002924641,0.00008231383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.007580461,0.003049208,0.1880349,0.0006077271,0.0003089696,0.4328355,0.001333431,0.003312198,0.07513012,0.001703741,0.00347191,0.282632],"study_design_scores_gemma":[0.0008556667,0.02054921,0.1779219,0.0002921311,0.0005339847,0.6275103,0.0006447015,0.01767262,0.1107098,0.00190177,0.04131897,0.00008903072],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894968,0.004280779,0.001433207,0.0007926848,0.0001305182,0.00004763584,0.00002710127,0.0000565844,0.003734644],"genre_scores_gemma":[0.9988798,0.0002818718,0.0001785906,0.0002331061,0.00005446509,0.000003793003,0.00002647596,0.000002967383,0.0003388481],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0005304607,"threshold_uncertainty_score":0.003396809,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3015555708","doi":"10.1136/jitc-2019-000313","title":"Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Merck KGaA; Pfizer","keywords":"Avelumab; Merkel cell carcinoma; Medicine; Expanded access; Merkel cell polyomavirus; Progressive disease; Merkel cell; Internal medicine; Oncology; Clinical trial; Chemotherapy; Carcinoma; Immunotherapy; Cancer; Nivolumab","authors":[{"name":"John Walker","is_ca":true},{"name":"Célèste Lebbé","is_ca":false},{"name":"Giovanni Grignani","is_ca":false},{"name":"Paul Nathan","is_ca":false},{"name":"Luc Dirix","is_ca":false},{"name":"Eyal Fenig","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Shahneen Sandhu","is_ca":false},{"name":"Rodrigo Ramella Munhoz","is_ca":false},{"name":"Elena Benincasa","is_ca":false},{"name":"Sarah Flaskett","is_ca":false},{"name":"Josh Reed","is_ca":false},{"name":"Arne Engelsberg","is_ca":false},{"name":"Vijay Kasturi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02488577820652711,"gpt":0.3496780509239403,"spread":0.3247922727174132,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001333968,0.0002391039,0.0003207478,0.0001391576,0.0002075804,0.0004144937,0.0002046013,0.0002082313,0.000983492],"category_scores_gemma":[0.0013036,0.00007370111,0.0002855754,0.0002336617,0.0003160495,0.0003718582,0.0003096265,0.0005841216,0.0001993026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004409325,"about_ca_system_score_gemma":0.000284614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002890809,"about_ca_topic_score_gemma":0.0004640867,"domain_scores_codex":[0.9996264,0.0001949708,0.0000256003,0.00004697681,0.0000575819,0.0000484196],"domain_scores_gemma":[0.9991018,0.0003253871,0.0001972474,0.00005485296,0.00006081127,0.000259882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03046205,0.008219473,0.2479689,0.0005416927,0.0008239741,0.003226537,0.001977897,0.002748247,0.04248637,0.0004506866,0.004773526,0.6563206],"study_design_scores_gemma":[0.02185147,0.1935285,0.7015995,0.0002941351,0.000859186,0.01885781,0.0006590215,0.003341098,0.02123958,0.0004442918,0.03724387,0.00008143252],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933469,0.004259666,0.0004132892,0.0002446383,0.000009636844,0.00005570528,0.0001035669,0.00001660806,0.001549967],"genre_scores_gemma":[0.9968779,0.001669958,0.0004766421,0.0002501642,0.00006458942,0.00003414645,0.0002913147,0.000008909128,0.0003263378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001333968,"threshold_uncertainty_score":0.007054746,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2997299711","doi":"10.1186/s40425-019-0816-5","title":"High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Stromal cell; Tumor microenvironment; Immune system; Cancer research; Immune checkpoint; Biology; Granzyme B; Ovarian cancer; CD8; Immunology; Cancer; Immunotherapy","authors":[{"name":"Heather MacGregor","is_ca":true},{"name":"Azin Sayad","is_ca":true},{"name":"Andrew Elia","is_ca":true},{"name":"Ben X. Wang","is_ca":true},{"name":"Sarah Rachel Katz","is_ca":true},{"name":"Patricia A. Shaw","is_ca":true},{"name":"Blaise Clarke","is_ca":true},{"name":"Sarah Q. Crome","is_ca":true},{"name":"Céline Robert-Tissot","is_ca":true},{"name":"Marcus Q. Bernardini","is_ca":true},{"name":"Linh T. Nguyen","is_ca":true},{"name":"Pamela S. Ohashi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01438185902002983,"gpt":0.2837279932218585,"spread":0.2693461342018287,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009938683,0.00008980771,0.0001148366,0.0004699706,0.0001926488,0.0002876291,0.00007402046,0.000168624,0.001962665],"category_scores_gemma":[0.0001267547,0.00009932695,0.0001026955,0.000241187,0.0002571091,0.0001229888,0.0001955934,0.0001931516,0.0002473477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001935853,"about_ca_system_score_gemma":0.0001486272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007837513,"about_ca_topic_score_gemma":0.0008868382,"domain_scores_codex":[0.9998797,0.00001521882,0.00001096151,0.00002827691,0.00002723474,0.00003868402],"domain_scores_gemma":[0.999881,0.00002001525,0.00003655712,0.00001035382,0.00001289958,0.00003915728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0006376307,0.00005122647,0.05032282,0.00005613163,0.00001682228,0.0002961987,0.00009987563,0.00006801547,0.9446663,0.0001623697,0.0001027148,0.003520021],"study_design_scores_gemma":[0.00006139148,0.0003601107,0.6704769,0.00001497382,0.00004514824,0.004206514,0.0006261895,0.001384923,0.3191288,0.0002856692,0.003397633,0.00001163526],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980581,0.0004980073,0.0004630429,0.00001795183,0.000001992752,0.00001063992,0.0001362068,0.00001533394,0.0007985263],"genre_scores_gemma":[0.9987884,0.0001618985,0.0003879465,0.00002588258,0.000004552316,0.00002028144,0.0002463759,0.00000681972,0.0003578123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001962665,"threshold_uncertainty_score":0.00656575,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4206536750","doi":"10.1136/jitc-2021-003289","title":"CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"Mitacs; Terry Fox Research Institute; McMaster University","keywords":"Glioblastoma; Tumor microenvironment; Immunotherapy; Medicine; Cancer research; Computer science; Computational biology; Internal medicine; Cancer; Biology; Tumor cells","authors":[{"name":"Mathieu Seyfrid","is_ca":true},{"name":"William Maich","is_ca":true},{"name":"Muhammad Vaseem Shaikh","is_ca":true},{"name":"Nazanin Tatari","is_ca":true},{"name":"Deepak Upreti","is_ca":true},{"name":"Deween Piyasena","is_ca":true},{"name":"Minomi Subapanditha","is_ca":true},{"name":"Neil Savage","is_ca":true},{"name":"Dillon McKenna","is_ca":true},{"name":"Nicholas Mikolajewicz","is_ca":true},{"name":"Hong Han","is_ca":true},{"name":"Chirayu Chokshi","is_ca":true},{"name":"Laura Kuhlmann","is_ca":true},{"name":"Amanda Khoo","is_ca":true},{"name":"Sabra K. Salim","is_ca":true},{"name":"Blessing Archibong-Bassey","is_ca":true},{"name":"William D. Gwynne","is_ca":true},{"name":"Kevin R. Brown","is_ca":true},{"name":"Nadeem Murtaza","is_ca":true},{"name":"David Bakhshinyan","is_ca":true},{"name":"Parvez Vora","is_ca":true},{"name":"Chitra Venugopal","is_ca":true},{"name":"Jason Moffat","is_ca":true},{"name":"Thomas Kislinger","is_ca":true},{"name":"Sheila K. Singh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01204532903169529,"gpt":0.294248444972102,"spread":0.2822031159404066,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009551323,0.0002349218,0.0002197618,0.0002382115,0.0001142212,0.0002707826,0.000137457,0.0001949304,0.0006664362],"category_scores_gemma":[0.00005164497,0.00005516029,0.0001633402,0.0001237516,0.0002070459,0.0001506034,0.0002042189,0.0002636163,0.0001633706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003806712,"about_ca_system_score_gemma":0.0002687802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006820942,"about_ca_topic_score_gemma":0.0009160924,"domain_scores_codex":[0.9999267,0.000009615974,0.000003782067,0.00001170616,0.00002015336,0.00002805672],"domain_scores_gemma":[0.9999747,0.000002481386,0.000007773447,0.000002367869,0.000004405691,0.000008295453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001340648,0.00005501453,0.0007129958,0.0001240041,0.000008275298,0.0001243825,0.00002629874,0.000419142,0.9869958,0.0003350127,0.0001880115,0.01087722],"study_design_scores_gemma":[0.00003165909,0.001191862,0.005419904,0.00001701089,0.00006609116,0.001020279,0.00005463204,0.002205261,0.9807499,0.0002122098,0.009023539,0.000007671985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839187,0.008800888,0.004902754,0.0002835827,0.00003599832,0.00006308319,0.0001439657,0.0001438323,0.001707137],"genre_scores_gemma":[0.9949844,0.002528965,0.001444112,0.00009090661,0.00001943233,0.00002932614,0.0001045724,0.000007887657,0.0007902623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006820942,"threshold_uncertainty_score":0.00276196,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2221239533","doi":"10.1186/s40425-015-0099-4","title":"Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptors","year":2015,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Terry Fox Foundation; Government of Ontario","keywords":"Chimeric antigen receptor; Antigen; Cytotoxic T cell; Degranulation; Ankyrin repeat; Tumor antigen; Antibody; Biology; Cancer research; Immunology; Cell biology; Receptor; Immunotherapy; Immune system; In vitro; Gene; Genetics","authors":[{"name":"Joanne A. Hammill","is_ca":true},{"name":"Heather VanSeggelen","is_ca":true},{"name":"Christopher W. Helsen","is_ca":true},{"name":"Galina Denisova","is_ca":true},{"name":"Carole Evelegh","is_ca":true},{"name":"Daniela Tantalo","is_ca":true},{"name":"Jennifer Bassett","is_ca":true},{"name":"Jonathan L. Bramson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04065385021059447,"gpt":0.3816428080727803,"spread":0.3409889578621859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002448205,0.0003863491,0.000181116,0.0001923724,0.0001049408,0.0002725849,0.000320998,0.0003729611,0.001085701],"category_scores_gemma":[0.0002692098,0.0001568236,0.0002228662,0.0001379395,0.0002005941,0.0002445371,0.0002480872,0.0005037896,0.0005573948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000329658,"about_ca_system_score_gemma":0.0001438754,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009922423,"about_ca_topic_score_gemma":0.0001533069,"domain_scores_codex":[0.9997662,0.00006126176,0.00002044277,0.00003847595,0.00007676759,0.00003680091],"domain_scores_gemma":[0.9998487,0.00003658032,0.00006276662,0.00001691548,0.00001749359,0.00001741494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0000778341,0.00002502051,0.0001301227,0.00006205747,0.000009634147,0.000116588,0.00001703511,0.000928398,0.9951082,0.0005020392,0.00008316214,0.002939865],"study_design_scores_gemma":[0.00003391997,0.0003304672,0.0005056878,0.000008248386,0.00001894597,0.0005994943,0.0000113765,0.002349632,0.9891767,0.0001441932,0.00681279,0.00000850655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9311397,0.00177644,0.06399959,0.0001338353,0.00006020724,0.0001622346,0.0002248537,0.0003717275,0.002131428],"genre_scores_gemma":[0.958039,0.0008000017,0.03706901,0.00008108515,0.00001184634,0.0001425289,0.0003923571,0.00007139775,0.003392706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001085701,"threshold_uncertainty_score":0.003632009,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}